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Abstract
The biological activity of the pharmaceutical drugs often depends on how it fits with a
receptor making stereochemistry a key component. Selective reactions can limit or avoid the
mixture of enantiomers obtained. One such reaction is the selective reduction of a carbon-carbon
double bond in the presence of a carbonyl. Although efficient, current asymmetric synthesis
methods have limitations such as harsh reaction conditions, the high costs of chiral catalysts and
the toxicity of the metal-based catalysts. Catalysts derived from small organic molecules have
become an attractive alternative which have been explored more rigorously in recent years. Using
a BINOL-derived boro-phosphate catalyst, we have developed a methodology that selectively
reduces the carbon-carbon double bond of linear α, β-unsaturated ketones, exclusively giving the
corresponding saturated ketone. To the best of our knowledge, this reaction is the first of its kind
to

accomplish

this

transformation and

results

give

high

yields

of

>93%

and

enantioselectivities >90% at room temperature. Furthermore, the products of this novel reaction
can be subjected to a choice electrophile, in example benzaldehyde, to afford diastereoselective
tertiary alcohol products with enantioselectivities of >88% and diastereoselectivities of up to 99:1.

xiv

Chapter 1 Applications of privileged ligands in asymmetric catalysis
1.1 Background
Asymmetric catalysis is one of the most prominent areas of organic synthesis due to the ever
growing need to make chiral drugs economically and enantiomerically pure.1,2 While the field has
achieved major breakthroughs in the last three decades, there are challenges that still limit the
efficiency of catalytic asymmetric methods.3 One such limitation in asymmetric catalysis is being
able to develop new chiral ligands which can lead to the discovery of new catalytic
reactions.4,5Although many approaches exists that can be employed in asymmetric synthesis, the
use of a chiral catalyst to control the stereochemical outcome of a reaction is one of the most
commonly used strategies. The desire to design cost effective catalysts that can achieve high levels
of enantioselective control has piqued the interest of researchers in this vast field.6 While these
catalysts have evolved in past decades from transition metal catalysts to organocatalysts, they share
the same general composition in that the stereochemical control is obtained from the chirality of
the ligand or scaffold. Despite the fact that there are a plethora of these chiral ligands exist7, there
is a particular group that exhibit extraordinary reactivity providing higher levels of stereochemical
in a wide range of reactions. Generally referred to as “privileged ligands”, BINAP (2, 2’diphenylphosphino-1, 1’-binapthyl), BINOL (1, 1’-bi-2-napthol), Bis (oxazoline), salen
complexes, and cinchona alkaloid derivatives possess exceptional reactivity and selectivity for a

1

wide range of reactions.

Figure 1. Privileged ligands and scaffolds used in asymmetric synthesis

These types of chiral ligands have been successfully applied in the synthesis of enantiopure
drugs on an industrial scale.8,9 In 1968, Knowles created one of the first asymmetric catalysts by
replacing the achiral triphenylphosphine ligands in Wilkinson's catalyst with the chiral phosphine
ligands.10 Experimentally, when used for an asymmetric hydrogenation, this catalyst gave a low
15% ee. Knowles later applied this method when he synthesized the key intermediate of L-3, 4dihydroxyphenylalanine (L-Dopa) while working for the Monsanto Company. By using rhodium
and the chiral (R,R)-1,2-Bis[(2-methoxyphenyl)(phenylphosphino)]ethane, better known as (R,R)DIPAMP (scheme 1), he successfully obtained the hydrogenated product with an ee of 95%.11
However, metal ligand catalysts have drawbacks in that they are expensive, produce toxic waste
and the removal of the catalyst can prove tedious.12

Scheme 1. Monsanto synthesis of L-Dopa

2

Ryoji Noyori, one of the most notable pioneers in the field of asymmetric catalysis, designed and
developed the BINAP ligand. The chiral BINAP-Ru (II) complexes have been used to efficiently
catalyze the asymmetric hydrogenation of acrylic acids.13

Figure 2. Chiral metal complexes

Scheme 2. Catalytic hydrogenation of (S)-Naproxen

(S)-Naproxen was successfully prepared by hydrogenation of acrylic acid 1 with (S)-BINAP-Ru
(II) catalyst (Scheme 3), which is an example of the utility of this methodology.14 This impact that
this ligand has had in the field of catalysis earned Noyori the Nobel Prize in chemistry in 2001.
1.2 Evolution of BINOL derived catalysts
1.2.1 Chiral BINOL-phosphoric acids
Although reports dating as far back as 1971 exist on the use of BINOL-phosphoric acids
as chiral resolving agents, it would be another 30 years before BINOL-derived chiral phosphoric
acids would gain mainstream popularity. In 2004, Akiyama and Terada independently reported on
the development of a new class of chiral Brønsted acids.15 Both BINAP and BINOL ligands are
based on a biphenyl core which can be fine-tuned by varying the substituents at the 3, 3’-positions.
The BINOL-derived phosphoric acids differ from the BINOLate complexes in that they have a
Brønsted acidic phosphoryl moiety. In the BINOLate complexes, the phosphoric acid moiety is
3

replaced by a transition metal which behaves as Lewis acid. The defining feature that makes
BINOL derived phosphoric acid catalysts unique how the “pocket” surrounds the binding site. The
large aryl groups confine the substrate, effectively transferring the stereochemical information to
the substrate.16,17 The presence of the Lewis acidic phosphoryl moiety in proximity to the acidic
proton potentially allows for bifunctional catalysis assisting in various non-racemic
transformations.18

Figure 3. Structural features of BINOL-derived phosphoric acid catalyst

The ability to alter the groups on the 3, 3′-positions of the BINOL backbone provides versatility
and more options for optimizing the reaction conditions.19 These catalytic systems with different
substituents 3, 3′-positions can be easily synthesized in few steps from commercially available
BINOL in both enantiomeric forms.20,21
1.2.2 Chiral BINOL-derived metal phosphates
Structurally similar to chiral phosphoric acids, chiral metal phosphates have been found to behave
as mild Lewis acid catalysts. Much like the phosphoryl moiety of the BINOL-derived phosphoric
acids, the transition metals provide their own unique reactivity.

4

Figure 4. Structural features of BINOL-derived phosphate salt

The mode by which the metal and the substrate interact in the presence of the chiral ligand can
provide enhanced selectivity for certain reactions. Although there are several hypotheses on the
mode of activation of the metal phosphates the two most commonly accepted forms involve the
phosphate anion acting as a counterion for the metal or a ligand.
Characterizing the interaction of the phosphate anion with the metal, the metal behaves as
a Lewis acid, while the phosphoric acid retains its Lewis basic site. Also, the ability of a metal
located within the cavity of the ligand to accept electron density further enhances the catalyst’s
ability to behave as an effective Lewis acid. This is a key feature that allows for the activation of
substrates possessing a reactive lone pair. Additionally, the multiple metal centers commonly
possess multiple coordination sites (figure 2), which can heighten the adaptability of how the chiral
phosphate controls the chiral space surrounding the metal center.
1.3 Chiral BINOL derived boro-phosphates catalyst
In 2010, Antilla et al reported a new high-yielding and highly enantioselective chiral Brønsted
acid-catalyzed allylboration of aldehydes. This approach gave a highly general methodology, with
a broad substrate scope that covers aryl, heteroaryl, α, β-unsaturated, and aliphatic aldehydes.22

5

Scheme 3. Chiral Brønsted acid catalyzed allylboration of aldehydes

Due to their importance as intermediates in both natural product synthesis and the synthesis
of pharmaceuticals, several methodologies have been developed for the synthesis of chiral
homoallyilic alcohols.23,24 Many of the allylation methodologies reported in recent years make use
of allylic silanes, allylic stannanes and allylic boranes/boronates.25 Unfortunately, these allylation
reagents are re difficult to prepare or are air/moisture-sensitive. Also, the use of undesirable metalbased catalysts such as tin, or substrates lead to toxic byproducts which makes these methods less
than desirable.
In 2012, Antilla26 et. al, reported a versatile and highly enantioselective chiral Brønsted
acid catalyzed method for the propargylation of aldehydes to provide a range of chiral
homopropargylic alcohols (scheme 4). At the time of the publication, alternative catalytic methods
had been limited to the use of allenylic or propargylic metal-based reagents or intermediates.
Application of the previously reported methodology by the Antilla group (scheme 3) to the
enantioselective propargylation of aldehydes proved successful. The methodology was simple and

6

highly efficient, demonstrating broad synthetic utility, and was the first Brønsted acid-catalyzed
propargylation of aldehydes for the synthesis of chiral homopropargylic alcohols.

Scheme 4. Chiral Brønsted acid catalyzed propargylation of aldehydes

The Antilla group reported yet another successful methodology for the asymmetric
reduction of ketones utilizing a chiral Brønsted acid as a precatalyst.27 This reduction used
catecholborane (CatBH) as the reducing agent, to give a highly enantioselective formation of chiral
secondary alcohols (figure 5). It was the first time chiral Brønsted acids as precatalysts were used
in this type of transformation. The reaction methodology was found to have a broad substrate scope
giving the desired secondary alcohols in yields up to 98% and enantioselectivities of up to 95%.

Figure 5. Asymmetric reduction of ketones catalyzed by phosphoric acid derivatives
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It was during this study in which the proposed pre-catalyst underwent a more rigorous
investigation. If in fact a different catalyst was forming when the phosphoric acid and the borane
reagent were mixed, there should be an observable change in the shifts of the reagents by 11B NMR.
Equal amounts of the chosen phosphoric acid catalyst and catecholborane were mixed using
deuterated toluene as the solvent under argon. As the two components mixed in the solvent, the
evolution of gas was observed which suggested that a reaction was indeed taking place (figure 6).

Figure 6. Proposed formation of boro-phosphate catalyst

The proton coupled
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B NMR spectrum provided further evidence that a reaction had taken place

due to the noticeable change of the resonance for catecholborane. The peak for catecholborane in
the 11B NMR spectrum was observed as a doublet at δ=28.73 ppm, which differed from the upfield
singlet seen in the spectrum of the solution containing the phosphoric acid and catecholborane
mixture.
Based on these findings, it was proposed that upon premixing, the phosphoric acid and
catecholborane form a new boro-phosphonate catalyst via the mechanism in figure 6. The
evolution of gas observed occurs when the hydride of catecholborane deprotonates the hydroxyl
group on the phosphoric acid. In turn, the oxygen of the acid forms a bond with the boron of the
catecholborane.

8

Figure 7. Proposed formation of boro-phosphate catalyst

Once the new catalytic species forms, the Lewis basic character of the phosphoryl group increases
the nucleophilicity of the catecholborane in the reaction. Furthermore, the boron of the
catecholborane moiety on the catalyst, activates the carbonyl of the reaction substrate forming a
chair like transition state shown in figure 7.

Figure 8. Interaction of boro-phosphate catalyst, borane and substrate
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The hydride of the free catecholborane adds to the carbonyl of the reaction substrate generating
the boro-phosphate catalyst ready to repeat. During the entire process the biaryl scaffold provides
the chiral environment in which the reaction is taking place.
1.4 Summary
Asymmetric catalysis has evolved in the last decade, expanding the scope of interest
beyond the traditional transition metal catalyst and organocatalysts. Even so, the search still
continues to find efficient and convenient reaction conditions to obtain products enantio- and
chemo-selectively. The versatility of catalytic systems with different substituents at the 3, 3

-

positions opens the door to explore the effectiveness of this catalyst in reactions not previously
studied. The commercial availability of BINOL in both enantiomeric forms adds to the ease of
accessing and creating novel catalytic systems that can be used in a wide range of reactions. The
effective use of BINOL-derived phosphoric acid catalysts in past reactions gives promising
potential for application in other reactions which have yet to be investigated. Similarly, the
excellent enantioselectivity obtained from the new derivative of the well-known chiral phosphoric
acid catalysts, makes the boro-phosphate a potential candidate for use in reactions still lacking
mild conditions and efficient methodologies.

10

Chapter 2 Boro-phosphate catalyzed asymmetric 1,4-reduction of α, β-unsaturated enones
2.1 Background
Catalytic asymmetric hydrogenations of functionalized olefins have been widely
investigated, and they can successfully be performed with modified ruthenium, rhodium and
iridium chiral complexes.28,29 It is important to note, that catalytic asymmetric hydrogenations of
functionalized olefins such as enamides, α, β-unsaturated carboxylic acids and esters, allylic and
homoallylic alcohols have been widely studied and examined. Although compounds with
stereogenic centers at the α- or β-position to a carbonyl group are synthetically important, they
have been less studied. The ability to control the regioselectivity of the enone would eliminate
obtaining an undesired product.30
In 1995, Takaya31 and co-workers employed BINAP-Ru (II) complexes as catalysts to
hydrogenate exo-cyclic enones, and they obtained 2-alkyl-substituted cyclic ketones with up to 98%
ee (scheme 7). In this case, there were limitations in that conversion of 2-aryl substituted substrates
gave a product with only 9% ee and the reactions only worked under high pressure and elevated
heat.

Scheme 5. Takaya BINAP-Ru (II) transfer hydrogenation
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The results obtained by Takaya and co-workers proved to further advance the investigations
on hydrogenation reactions, but room for improvement still existed.

Figure 9. MacMillan et al. Enantioselective Organocatalytic Hydride Reduction

Others, such as List and MacMillan, found that organocatalytic transfer hydrogenations using
Hantzsch esters (figure 9) provided excellent enantioselectivity.

Figure 10. tert-butyl valinate and chiral TRIP-PA

List32 reported an efficient and highly enantioselective conjugate transfer hydrogenation of α, βunsaturated ketones catalyzed by a salt shown in figure 10, made from tert-butyl valinate and a
chiral phosphoric acid catalyst (TRIP). However, for linear enones these methodologies had
limitations affording an ee max of only 70% (figure 11).
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Figure 11. List enantioselective conjugate transfer hydrogenation

MacMillan33 reported a new organocatalytic strategy for the first enantioselective
organocatalytic transfer hydrogenation of cyclic enones. This reaction (figure 12) provided access
to α-substituted cycloalkenones chemoselectively, in high yield and 74% ee.

Figure 12. MacMillan organocatalytic transfer hydrogenation of cyclic enones

Although advances have been made in the field of asymmetric synthesis, the ability to
enantioselectively create stereogenic carbon centers still faces challenges. The necessity to develop
strategies to perform such a transformation is driven by need to synthesize biologically active
molecules containing hydrogen containing stereogenic carbon centers.34,35 Problems arise due to
the reactive nature of both the carbonyl and alkenic double bond.36,37
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Figure 13. Reactive sites of α, β-unsaturated ketones

To date, a plethora of methods have been reported which allow for the chemo- and
enantioselective reduction of the carbonyl moiety of α, β-unsaturated ketones.38,39 However,
methods which chemoselectively target the carbon-carbon (figure 13) double bond are rare 40, with
the majority relying on organometallic catalysts. Although efficient enantioselective transfer
hydrogenation strategies are known in the literature for cyclic α, β-unsaturated ketones and
aldehydes, methodologies for linear systems are limited.22,27
2.2 1,4-reduction of α, β-unsaturated enones
2.2.1 Catalyst Screening
We began our investigation by determining which PA catalyst (figure 14) would be the
best promoter for the reaction. Several (R)-BINOL-derived PA catalysts were synthesized as well
as a (R)-VAPOL-derived PA. Reactions catalyzed by PA catalysts derived from the H8-BINOL
share similar qualities with the BINOL-derived PA catalysts, but differ in solubility and steric
effects due to the hydrogenated portion of the scaffold.41 With this in mind, it was beneficial to
see if modification of the scaffold as well as the substituents at the 3, 3’-positions may enhance
the selectivity.

14

Figure 14. Chiral phosphoric acid catalysts used in methodology screening

This series of PA catalysts were screened with (E)-1, 3-diphenyl-2-buten-1-one as the enone,
pinacolborane (HBPin) as the reducing agent in anhydrous toluene at 50°C (Table 1). Under these
conditions, (R)-BINOL-derived PA1 (table 1, entry 1, 68% ee) and PA2 (entry 2, 52% ee) were
the best performing catalysts with a conversion to product >90%. The PA catalyst derived from
(R)-H8-BINOL, PA4 (table 1, entry 4, 41% ee) did not show any significant improvement in
enantioselectivity and the (R)-VAPOL-derived PA9 (table 1, entry 7) gave the worst over all
result with only a 4% conversion to product.
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Table 1. Screening of various BINOL-derived PA catalysts

Although these results showed promise, the reaction needed to be heated to reach completion.
Unfortunately, as the reaction temperature increased, the enantioselectivity decreased. Heating the
reaction to 50°C in toluene gave the best results considering the effects of heating on the
enantioselectivity. Albeit moderate, these initial results encouraged us to use (R)-PA1 and (R)PA2 as our choice PA catalysts.
2.2.2 Solvent Screening
Since the 1,4-reduction in toluene required heating, other solvents were investigated. An
ideal solvent would allow for the reaction to be run at lower temperatures while proceeding to
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completion. If in the end toluene proved to be the best solvent, the reaction temperature would
need to be addressed.
Table 2. Screening of various solvents with (R)-PA1 catalyst

We continued our investigation by conducting an extensive solvent screening as shown
in table 2, at room temperature. Ideally, a reaction that can proceed to completion at room
temperature would provide the most convenient conditions. Along with simplifying the reaction
conditions, using a lower reaction temperature would also improve the enantioselectivity.
Although high conversion was achieved with toluene at 50°C, at room temperature only 44%
(table 2, entry 4) conversion was observed. At room temperature, aromatic solvents such as m-
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xylenes (table 2, entry 5) and p-xylenes (table 2, entry 6) gave poor conversion to product, while
benzene (table 2, entry 9) performed similar to toluene in conversion and selectivity. We then
proceeded to examine the reaction in aliphatic solvents. Linear aliphatic solvent, hexanes (table
3, entry 10) gave moderate enantioselectivity (70% ee), but gave only 37% conversion to product.
To our delight, in cyclohexane (table 2, entry 12), the reaction gave full conversion proving to be
the best solvent, showing a dramatic increase in enantioselectivity at room temperature (87% ee).
2.3 Substrate synthesis and scope
Inspired by our preliminary findings, various β, β-disubstituted α, β-unsaturated ketones were
synthesized to be screened for the substrate scope. The α, β-unsaturated ketones were synthesized
(figure 15) via a Horner-Wadsworth-Emmons olefination to the α, β-unsaturated ethyl ester, which
can then be readily converted to the Weinreb amide.42 This method allowed for variation at the R1,
R2 and R3 positions and worked fairly well for most disubstituted ketones giving α, β-unsaturated
ethyl esters.

Figure 15. Traditional synthesis of α, β-unsaturated ketones via HWE reaction

At this stage we found that while it was easy to separate the E/Z α, β-unsaturated ethyl ester isomers
formed, not all were so proved easily separate by column chromatography.

Due to these

complications, we also explored alternative methods for the synthesis our test substrates.
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Figure 16. Route for the synthesis of α, β-unsaturated ketones

In order to expedite the route to the desired α, β-unsaturated ketones, we improved the method
by which the Weinreb amide can be accessed. With slight improvements upon a lesser known
strategy, the ylide was synthesized with the Weinreb amide moiety (scheme 6).

Scheme 6. Synthesis of specialized Weinreb ylilde

Once synthesized, specialized ylide can be stored and used at a later time which provides added
convenience to this alternative synthetic pathway. The ylide can then be used to synthesize the β,
β-disubstituted α, β-unsaturated Weinreb amides in two-steps from various commercially
available ketones or aldehydes shown in scheme 7.

Scheme 7. Synthesis of α, β-unsaturated ketones via HWE using specialized Weinreb ylide

Simple Grignard addition to the Weinreb amide installs the group at R3, providing rapid access
to a wide variety of α, β -unsaturated ketones.
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2.4 Results and Discussion
With the test substrates in hand, we re-examined the PA catalysts bearing similar aromatic
substituents at the 3, 3’-position. Originally, the catalysts were tested using enone 1a,
pinacolborane (HBPin) as the reducing agent in anhydrous toluene at 50°C (Table 1). These
conditions showed that (R)-PA1 gave the best selectivity prompting us to use (R)-PA1 for the
solvent screening. The results of the solvent screening showed cyclohexane as the best
performing solvent at room temperature, eliminating the need to use heat for the reaction. We
proceeded to screen catalysts (R)-PA1, (R)-PA2, (R)-PA3 and (R)-PA4 in cyclohexane to rule
out any possibility of finding a more selective catalyst.
Table 3. Re-screening of catalysts with similar substituents at the 3, 3’-positions
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It is well known that the biaryl scaffold of BINOL-derived catalysts can be tuned by
changing the group at the 3, 3’-positions. We observed this effect when the results showed a wide
variation in the enantioselectivity. Overall, (R)-PA2 emerged as the best PA catalyst
demonstrating superior enantiocontrol (table 3, entry 2) and we proceeded to use this catalyst to
examine the substrate scope.
Substrates containing an aromatic ring at R1 and a -CH3 at R2 at the β-position. Based on
the excellent result obtained with (E)-1, 3-diphenyl-2-buten-1-one, we proceeded to try our
methodology on α, β-unsaturated ketones substrates in which the R1, R3=aryl groups had electronwithdrawing (table 4, entry 2h, 2k) or electron-donating substituents (table 4, entry 2d). We were
pleased to observe that these substrates reacted extremely well and were reduced with high
enantioselectivity. Also, heterocyclic substituents at R1 did not diminish the reactivity or the
enantioselectivity of the reaction (table 4, entry 2j).
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Table 4. Boro-phosphate catalyzed 1,4-reduction of α, β-unsaturated ketones

Although chalcones with an aliphatic substituent at R2 were reduced, we were
disappointed by the moderate results obtained using the two catalyst with best selectivity (table
5). The poor selectivity for substrates with aliphatic substituents at R1 and R2 suggested that the
aromatic ring at the β-position plays a key role in the selectivity of the reaction (table 5, entry 2o).
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Table 5. Reductions of α, β-unsaturated ketones with variation at the β-position

This can be observed in table 5, entry 2p in which again there is only moderate selectivity with
an aromatic ring tethered to an aliphatic chain at the β-position. Even with an aromatic group
directly attached to the β-position (table 5, entry 2p), the group at R2 appears to also have an
influence in the selectivity of the reaction. Replacing the -CH3 group at R2 with a -CF3 group
stopped the reaction from taking place with no reaction being observed in table 5, entry 2q.
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Table 6. Geometry of enone influence in boro-phosphate reduction

Furthermore, we were impressed to observe that when the catalyst loading for (R)-PA2 was
lowered to 2 mol %, the reaction proceeded to full conversion with 94% ee. Similarly, even at a
low catalyst loading of 1 mol % full conversion was achieved, albeit with a moderate drop to 88%
ee. Overall, a catalyst loading of 2 mol % was used for the methodology (table 7).
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Table 7. Substrate scope of methodology

The substituents that had a significant impact on the enantioselectivity of the reaction
were those with either an α-naphthyl or β-naphthyl or aliphatic chain at R1. We were surprised to
observe that the substrate with α-naphthyl at the R1 position gave better selectivity with (R)-PA1,
the catalyst bearing an α-naphthyl at the 3, 3’-positions (table 7, entry 2c). Similarly, the
substituent with a β-naphthyl at R1 gave better selectivity with (R)-PA2, which had β-naphthyl
groups at the 3, 3’-positions (table 7, entry 2b). When compared to the reported literature values,
the experimental values (1H NMR, optical rotation, HPLC, etc.) of the products synthesized were
in accordance to the published values. This information allowed us to establish the relative and
absolute stereochemistry of the compounds. The results we observed with these substrates
prompted us to investigate the mechanism of the reaction to try to better understand the selectivity.
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2.5 Mechanistic Observations
2.5.1 Comparison of enone geometry
It is well known that cyclic α, β-unsaturated ketones, such as 2- cyclohexanone, are locked
into the s-trans conformation.43 However, for acyclic substrates such as 1, 3-diphenyl-2-buten-lone (dypnone), its two geometrical isomers can undergo s-cis/s-trans conformational equilibrium
(figure 17). This becomes important due to the fact that the geometry of the enone bears
importance on the enantioselectivity of the reaction. The trans-s-cis conformation of (E)-dypnone
has been shown to be the most stable conformation of this substrate, while the (Z)-dypnone is
overall unstable.44 To further investigate the reactivity of each isomer, mixtures of different ratios
of E/Z-isomers were subjected to the reaction conditions.

Figure 17. Different conformations of E/Z-isomers

As shown in table 8, when the reaction is performed with a mixture of E/Z isomers, the
enantioselectivity decreases (table 8, entry 4, and entry 5). There was also an observable decrease
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in the conversion of the reaction. A 1:1 mixture of E/Z isomers (table 3, entry 3)
demonstrated that after 24 hours, there was only a 50% conversion to product observed by
1

HNMR.
Table 8. Effect of enone geometry on product outcome

The enantioselectivity dropped from 94% ee (table 8, entry 1) to 70% ee (table 8, entry 3). This
suggests that the selectivity also depends on the geometry of the substrate and that the (Z)-isomer
is less reactive under the conditions (table 8, entry 5). Taking into considerations the relative
stabilities of the conformations of each isomer, one can speculate that the poor reactivity and
selectivity of (Z)-dypone can be attributed to its unfavorable conformations. For the ideal
enantioselectivity, it is preferable to use the reaction conditions on isomerically pure (E)-enone
(table 8, entry 1).
2.5.2 Comparison of α-naphthyl or β-naphthyl substituents on 3, 3’- position of PA
The most interesting results are observed in substrates bearing α-naphthyl or βnaphthyl substituents at R1. When the chalcone bearing the β-naphthyl substituent at the βcarbon was subjected to the reaction condition using (R)-PA1 (3, 3’=α-naphthyl) or (R)-PA2
(3, 3’=β-naphthyl), only a minor difference was observed in enantioselectivity. However,
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when the chalcone bearing the α-naphthyl substituent at the β-carbon was treated in the same
fashion, there was a dramatic difference in enantioselectivity. For this substrate (table 4,
entry 3), (R)-PA1 emerged as the superior catalyst resulting in an 87% ee.
Table 9. Selectivity comparison of (R)-PA1 and (R)-PA2

Furthermore, although (R)-BINOL was used to synthesize the catalysts used for the
study, we were intrigued by the fact there was a switch in the conformation of the resulting
product. Under the same conditions, the substrates reduced using (R)-PA1 preferentially
gave the (R)-enantiomer (table 9, entry1)., whereas in reactions with (R)-PA2 were selective
for the (S)-enantiomer (table 9, entry 2). When the (S)-BINOL-derived PA1 and PA2 were
used (table 4, entry 2) a change in selectivity was observed in which now the (S)-PA1 and
(S)-PA2 gave the (S)-enantiomer and the (R)-enantiomer respectively.
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To better understand why such a switch in selectivity was observed, computational
studies were conducted to gather insight into the mechanism of the reaction. The Becke,
three-parameter, Lee-Yang-Par (B3LYP) calculations tend to be the most commonly used
methods for computational chemistry practitioners.45 When trying to examine organic
reactions, B3LYP works particularly well for organic molecules and was the density
functional method of choice used by our collaborator Eri Yamamoto, a graduate student in
the lab of Dr. Masahiro Yamanaka at Rikkyo Univeristy in Tokyo, Japan.

Figure 18. Computational methods used for structural studies

For the study of the catalyst structure, a chemical model and the density functional theory (DFT)
computational method were used. Various conformations (local minimum structures) of (R)-PA1
and (R)-PA2 were optimized at the ONIOM (B3LYP/6-31G*: HF/3-21G) level. To elucidate the
stereocontrol of PA1 and PA2 catalyzed 1,4-reduction of α, β-unsaturated ketone, the initial DFT
calculations were performed in on a simplified chemical model (figure 19) in which the aryl rings
and the methyl groups of the pinacolborane were removed.
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Figure 19. Representation of the simplified model

The two diastereomeric TSs [TS_R leading to (R)-product, TS_S leading to (S)-product]
were located at the B3LYP/6-31G* level. In both TS_S and TS_R, the phosphoro-boronate
catalyst simultaneously activates α, β-unsaturated ketone and boron on Lewis acidic boron and
Lewis basic phosphoryl oxygen, respectively, to form cyclic TS.

Figure 20. Simplified structural model

This indicates that the relative stability of the diastereomeric TSs depends on the
asymmetric reaction space constructed by the 3, 3’-substituents.
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Figure 21. Structures of (R)-PA1 and (R)-PA2

Detailed density functional theory (DFT) for the transition state energy of the
reactions included those for the different isomers (s-cis and s-trans) of compound 1a. Also,
the relative orientation of the 3, 3’-naphthyl group was explored (figure 21). The
conformations bearing the hydrogen bond between the naphthyl-H at the ortho position and
the phosphoryl oxygen are relatively stabilized.
The computational model (figure 22) shows that hydrogen bonding stabilizes the
transition state between the borate-O and phenyl of the substrate in TS_R. Also, the
calculated bond length between the phosphoryl-O and naphthyl-H is shorter in TS_S than
TS_R. The energy difference between TS_R and TS_S can be attributed to the
destabilization of the hydrogen bonding caused by the steric repulsion induced by the methyl
of the substrate and 3, 3’-substituent of the catalyst.
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Figure 22. (R)-PA1 and (R)-PA2 transition state computational model

Disruption of this interaction is fundamental to the energy difference observed leading to a
preference of PA1 for the (R)-enantiomer. Therefore, it is the steric interaction of the
substituents at the β-carbon and the 3, 3’-substituents of the PA (Figure 17) which influence
the facial selectivity leading to the respective major enantiomer.
2.6 Summary
Under the optimized conditions of our methodology, the BINOL-derived boro-phosphate
catalyst successfully reduced linear α, β-unsaturated ketones are selectively reduced at the carboncarbon

double

bond,

giving

the

corresponding

saturated

ketone

in

yields

and

enantioselectivities >93% with 2 mol % catalyst loading. α, β-Unsaturated ketones substrates with
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electron withdrawing or electron donating substituents on the R1, R3=aryl groups did not exhibit
reduced the enantioselectivity, and heterocyclic groups at R1 were well-tolerated. The
computational studies suggest that the stereoelectronic effects of the substituents at the β-carbon
and the 3, 3’-substituents of the PA influence the facial selectivity that leads to the respective
major enantiomer.
2.7 Experimental
2.7.1 General Considerations
Unless otherwise noted, all reactions were carried out in flame-dried screw-cap test tubes
and were allowed to proceed under a dry argon atmosphere with magnetic stirring. Anhydrous
solvents were purchased from commercial sources and used without further purification. Ketones
were purchased from commercial sources and used without further purification. PA catalysts were
prepared from chiral BINOL according to the known literature procedure.46 Thin layer
chromatography was performed on Merck TLC plates (silica gel 60 F254). Ketones were purchased
from commercial sources without any further purification. Thin layer chromatography was
performed on Merck TLC plates (silica gel 60 F254). Visualization was accomplished using UV
light (256 nm), p-anisaldehyde or potassium permanganate stain as indicator. Flash column
chromatography was performed with Merck silica gel (230-400 mesh). Analytical Autopol IV
polarimeter (589) using a 700-µL cell with a path length of 1-dm. 1H NMR and 13C NMR were
recorded on a Varian Inova-400 spectrometer with chemical shifts reported relative to
tetramethylsilane (TMS). Data were recorded as follows: chemical shift in ppm from internal
tetramethylsilane, multiplicity (s = singlet; d = doublet; t = triplet; q = quartet; m = multiplet; br =
broad), coupling constant (Hz), integration, and assignment. All the compounds were known
compounds and were characterized by comparing their 1H NMR and
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C NMR values those

reported in the literature. Enantioselectivity was determined using a Varian Prostar HPLC and
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Chiralcel AD-H, OD-H, or AS-H chiral columns. All reactions were conducted in triplicate to
ascertain reproducibility.
2.7.2 General procedure for the reduction of α, β-unsaturated enones

A screw-cap reaction tube loaded with a stir bar was evacuated, flame-dried, and backfilled with argon. Once the screw-cap reaction tube was cooled to room temperature, (R)-PA
catalyst PA2 (2 mol %) and anhydrous cyclohexane (0.5ml) were added and left to stir. To this
mixture was added HBpin (1.5 equiv.) and the mixture was stirred approximately 1 minute before
adding α, β-unsaturated ketone (0.25 mmol) in anhydrous cyclohexane (0.5ml). The reaction
mixture was monitored by TLC (hexanes/EtOAc 10:1) and stirred at room temperature for 12-24
hours at room temperature. Upon completion the reaction was quenched with deionized water
(1.0ml) and extracted with diethyl ether. The combined organic layers were washed with brine,
dried over Na2SO4, and concentrated in vacuo. The crude residue was then purified by flash
chromatography. The eluent was collected in Fisherbrand™ disposable borosilicate glass tubes
with plain end (Cat. No. 14-961-29 16x100mm) and the corresponding fractions were visualized
by TLC using UV light (256 nm). The fractions containing the desired product were then collected
and concentrated in vacuo. Enantiomeric excess was determined by chiral normal phase HPLC.
The details of column type and run conditions are described below.
The relative stereochemistry (R or S) was assigned based on the published literature values by
assigning the experimental retention times to the literature retention times. In the literature47, the
first peak to elute was designated to be the (S)-enantiomer and the second peak to elute off the
column was designated to be the (R)-enantiomer. Based on this published data, we assigned the
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corresponding stereochemical designation to our chromatographic data. The assignment for the
peak with the experimental optical rotation values were compared to the published literature values
and determined to coincide based on the assignment by spectroscopic data of the published work.
Absolute configuration was assigned by analogy based on the optical rotation data of known
compounds reported in the literature and the sign of optical rotation is noted.

(S)-1,3-diphenylbutan-1-one (2a): Following the general procedure for the reduction of α, βunsaturated enones, purification by column chromatography (hexane/EtOAc, 10:1→5:1) and
preparative TLC (hexane/EtOAc, 5:1) the title compound was obtained as a white solid in 96 %
yield. The spectroscopic data was consistent with the literature data, the absolute configuration
was assigned in comparison of the optical rotation reported and relative stereochemistry was
assigned based on the HPLC retention times reported in the literature.48 Enantiomeric excess was
determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor
= 7.185 min, tminor = 9.131 min; ee = 94%. [α]25D = +0.71 (c=1.87, CHCl3), literature value28 [α]RTD
= +0.57 (c=1.0, CHCl3) 81% ee, S enantiomer ; 1H NMR (400 MHz, CDCl3): δ 7.93 (d, J = 7.2
Hz, 2H), 7.59-7.51 (m, 1H), 7.48-7.40 (m, 2H), 7.35-7.18 (m, 5H), 3.58-3.43 (m, 1H), 3.30 (dd, J
= 16.5, 5.4 Hz, 1H), 3.18 (dd, J = 16.5, 8.4 Hz, 1H), 1.34 (d, J = 6.9 Hz, 3 H); 13C NMR (100 MHz,
CDCl3): δ 199.1, 146.6, 137.3, 133.0, 128.6, 128.1, 126.9, 126.3, 47.0, 35.6, 21.9.
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(S)-3-(naphthalen-2-yl)-1-phenylbutan-1-one (2b): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column chromatography (hexane/EtOAc,
10:1→5:1) and preparative TLC (hexane/EtOAc, 5:1) the title compound was obtained as a yellow
oil in 96 % yield. The spectroscopic data was consistent with the literature data, the absolute
configuration was assigned in comparison of the optical rotation reported and relative
stereochemistry was assigned based on the HPLC retention times reported in the literature.49
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH =
99.5/0.5, 1.0 mL/min), tmajor = 12.321 min, tminor = 15.865 min; S-enantiomer= 95% ee. [α]25D =
+1.14 (c=0.97, CHCl3), literature value50 [α]20.0D = -4.54 (c=0.44, CHCl3) R-enantiomer=97% ee;
1

H NMR (400 MHz, CDCl3): δ 7.93 (d, J = 7.2 Hz, 2H), 7.81-7.76 (m, 3H), 7.69 (s, 1H), 7.55-

7.48 (m, 1H), 7.47-7.35 (m, 5H), 3.74-3.60 (m, 1H), 3.39 (dd, J = 16.5, 5.7 Hz, 1H), 3.26 (dd, J =
16.5, 8.1 Hz, 1H), 1.41 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 199.0, 144.1, 137.3,
133.6, 133.0, 132.3, 128.6, 128.2, 128.1, 127.7, 127.6, 126.0, 125.8, 125.4, 125.0, 45.0, 35.7, 21.9.

(R)-3-(naphthalen-1-yl)-1-phenylbutan-1-one (2c): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 10:1→5:1) and
preparative TLC (hexane/EtOAc, 5:1) the title compound was obtained as a white solid in 91 %
yield. The spectroscopic data was consistent with the literature data, the absolute configuration
was assigned in comparison of the optical rotation reported and relative stereochemistry was
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assigned based on the HPLC retention times reported in the literature.51 Enantiomeric excess was
determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor
= 11.0463 min, tminor = 15.029 min; ee = 87%. [α]25D = -1.99 (c=0.82, CHCl3); 1HNMR (400 MHz,
CDCl3) δ 7.99 (s, 1H), 7.82 – 7.74 (m, 3H), 7.65 (s, 1H), 7.42 (dd, J = 23.4, 5.3 Hz, 4H), 7.32 (t,
J = 6.0 Hz, 3H), 3.60 (s, 1H), 3.21 (s, 1H), 2.98 (s, 1H), 1.56 – 1.43 (m, 3H); 13CNMR (100 MHz,
CDCl3) δ 199.04, 140.36, 136.88, 134.49, 132.69, 132.34, 129.14, 128.83 – 128.51, 128.51 –
128.30, 128.06, 127.25, 126.97, 125.28, 123.21, 47.35, 37.39, 20.64.

(S)-3-(4-methoxyphenyl)-1-phenylbutan-1-one (2d): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 10:1→5:1) and
preparative TLC (hexane/EtOAc, 5:1) the title compound was obtained as a white solid in 92 %
yield. The spectroscopic data was consistent with the literature data, the absolute configuration
was assigned in comparison of the optical rotation reported and relative stereochemistry was
assigned based on the HPLC retention times reported in the literature.52 Enantiomeric excess was
determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor
= 12.703 min, tminor = 17.621; S-enantiomer= 90% ee. [α]31.4D = +2.33 (c=0.98, CHCl3), literature
value50 [α]24.0D = -6.87 (c=1.39, CHCl3), R-enantiomer= >98% ee; 1 HNMR (400 MHz, CDCl3): δ
7.92 (d, J = 7.2 Hz, 2H), 7.58-7.40 (m, 3H), 7.18 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 3.77
(s, 3H), 3.48-3.39 (m, 1H), 3.26 (dd, J = 16.5, 6.0 Hz, 1H), 3.14 (dd, J =16.5, 8.1 Hz, 1H), 1.31
(d, J = 6.9 Hz, 3H); 13CNMR (100 MHz, CDCl3): δ 199.3, 158.0, 138.7, 137.3, 133.0, 131.0, 128.6,
128.1, 127.8, 113.9, 55.3, 47.3, 34.9, 22.1.
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(S)-1-(4-methoxyphenyl)-3-phenylbutan-1-one (2e): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 10:1→5:1) and
preparative TLC (hexane/EtOAc, 5:1) the title compound was obtained as a white solid in 72 %
yield. The spectroscopic data was consistent with the literature data, the absolute configuration
was assigned in comparison of the optical rotation reported and relative stereochemistry was
assigned based on the HPLC retention times reported in the literature.53 Enantiomeric excess was
determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor
= 19.662 min, tminor = 30.605 min; ee = 93%. [α]25D = -0.91 (c=0.66, CHCl3); 1HNMR (400 MHz,
CDCl3): δ 7.92 (d, J = 8.9 Hz, 2H), 7.32-7.26 (m, 4H), 7.21-7.17 (m, 1H), 6.91 (d, J = 8.9 Hz, 2H),
3.86 (s, 3H), 3.53-3.45 (m, 1H), 3.24 (dd, J = 16.2, 5.7 Hz, 1H), 3.13 (dd, J = 16.2, 8.4 Hz, 1H),
1.33 (d, J = 7.0 Hz, 3H); 13CNMR (100 MHz, CDCl3) δ 198.1, 163.8, 147.1, 130.8, 130.7, 128.9,
127.3, 126.6, 114.1, 55.9, 47.1, 36.2, 22.3. HRMS calculated for C17H18O2: 277.1199; found
277.1206.

(S)-3-(4-fluorophenyl)-1-phenylbutan-1-one (2f): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 10:1→5:1) and
preparative TLC (hexane/EtOAc, 5:1) the title compound was obtained as a white solid in 95%
yield. The spectroscopic data was consistent with the literature data, the absolute configuration
was assigned in comparison of the optical rotation reported and relative stereochemistry was
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assigned based on the HPLC retention times reported in the literature.50 Enantiomeric excess was
determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor
= 8.948 min, tminor = 11.630 min; S-enantiomer= 91%. [α]25D = +1.12 (c=1.3, CHCl3) ), literature
value50 [α]28.8D = -1.21 (c=1.54, CHCl3) R-enantiomer=>98% ee ;1 HNMR (400 MHz, CDCl3) δ
1.30 (d, J = 6.8 Hz, 3H), 3.17 (dd, J = 7.6, 16.8 Hz, 1H), 3.27 (dd, J = 6.0, 16.8 Hz, 1H), 3.48–3.53
(m, 1H), 6.95–7.00 (m, 2H), 7.21–7.26 (m, 2H), 7.42–7.46 (m, 2H), 7.53–7.57 (m, 1H), 7.90–7.92
(m, 2H); 13CNMR (100 MHz, CDCl3) δ 198.57, 163.68, 161.59, 143.40, 143.37, 136.95, 132.71,
128.65, 128.43, 128.05, 127.98, 115.65, 115.43, 47.93, 38.19, 21.12.

(S)-1-(4-fluorophenyl)-3-phenylbutan-1-one (2g): Following the general procedure for the
reduction of α, β-unsaturated enones, the title compound was obtained in 92% yield. Enantiomeric
excess was determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0
mL/min), tmajor = 8.749 min, tminor = 11.421 min; ee = 95%. [α]25D = -2.11 (c=1.58, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 7.83 – 7.79 (m, 2H), 7.31 – 7.24 (m, 4H), 7.16 (s, 1H), 7.13 – 7.06 (m,
2H), 3.45 (s, 1H), 3.15 (s, 1H), 2.93 (s, 1H), 1.44 – 1.30 (m, 3H); 13CNMR (100 MHz, CDCl3) δ
199.04, 166.40, 146.61, 133.79, 130.89 – 130.23, 128.41 – 128.20, 127.32 – 126.92, 126.60,
116.98 – 114.69, 47.9, 38.8, 21.12.
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(R)-1-phenyl-3-(4-(trifluoromethyl) phenyl)butan-1-one (2h): Following the general procedure
for the reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 10:1→5:1)
and preparative TLC (hexane/EtOAc, 5:1) the title compound was obtained as a white solid in 93%
yield. The spectroscopic data was consistent with the literature data, the absolute configuration
was assigned in comparison of the optical rotation reported and relative stereochemistry was
assigned based on the HPLC retention times reported in the literature.50 Enantiomeric excess was
determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor
= 7.137 min, tminor = 9.755 min; R-enantiomer= 96% ee. [α]25D = -4.20 (c=0.96, CHCl3), literature
value50 [α]24.0D = -5.22 (c=0.78, CHCl3) R-enantiomer= 89% ee; 1 HNMR (400 MHz, CDCl3) δ
1.36 (d, J = 7.19 Hz, 3H), 3.23 (dd, J = 7.6, 16.7 Hz, 1H), 3.32 (dd, J = 6.4, 16.8 Hz, 1H), 3.56–
3.60 (m, 1H), 7.38–7.46 (m, 3H), 7.54–7.56 (m, 3H), 7.90–7.93 (m, 2H);
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CNMR (100 MHz,

CDCl3) δ 21.8, 35.3, 46.5, 124.2 (q, 1 J = 270.8 Hz), 125.5 (q, 3 J = 4.1 Hz), 127.2, 128.0, 128.5
(q, 2 J = 32.1 Hz), 128.6, 133.1, 137.0, 150.6, 198.4.

(S)-3-(4-chlorophenyl)-1-phenylbutan-1-one (2i): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 10:1→4:1) and
hexane/EtOAc, 4:1) and preparative TLC (hexane/EtOAc, 4:1) the title compound was obtained
as a white solid in 92% yield. The spectroscopic data was consistent with the literature data and
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the absolute configuration was assigned in comparison of the optical rotation with the literature
value54 Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column
(hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor = 9.041 min, tminor = 12.659 min; S-enantiomer=
92%. [α]25D = -1.24 (c=1.1, CHCl3), literature value50 [α]24.0D = -1.76 (c=1.30, CHCl3) Senantiomer= 95% ee; 1HNMR (400 MHz, CDCl3): δ 7.94-7.91 (m, 2 H), 7.58-7.43 (m, 3 H), 7.287.19 (m, 4 H), 3.53-3.47 (m, 1 H), 3.27 (dd, J = 16.6, 6.3, 1 H), 3.18 (dd, J = 16.6, 7.8, 1 H), 1.32
(d, J = 6.8, 3 H); 13CNMR (100 MHz, CDCl3) δ 198.88, 145.19, 137.23, 133.31, 132.05, 128.82,
128.48, 128.24, 47.01, 35.14, 22.17.

(S)-1-phenyl-3-(thiophen-2-yl)butan-1-one (2j): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 4:1) and preparative
TLC (hexane/EtOAc, 4:1) the title compound was obtained as a white solid in 93% yield. The
spectroscopic data was consistent with the literature data, the absolute configuration was assigned
in comparison of the optical rotation reported and relative stereochemistry was assigned based on
the HPLC retention times reported in the literature.55 Enantiomeric excess was determined by
HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor = 8.161 min,
tminor = 9.559; S-enantiomer= 87% ee. [α]33.3D = +1.37 (c=0.97, CHCl3, literature value50 [α]24.0D =1.42 (c=2.04, CHCl3), R-enantiomer= >98% ee; 1HNMR (400 MHz, CDCl3) δ 7.88 – 7.77 (m, 8H),
7.42 (s, 4H), 7.38 – 7.33 (m, 8H), 7.01 – 6.86 (m, 12H), 3.41 (s, 3H), 3.13 (s, 3H), 2.80 (s, 3H),
1.53 – 1.39 (m, 12H); 13CNMR (100 MHz, CDCl3) δ 201.06, 146.12, 136.88, 132.69, 128.83 –
128.46, 128.46 – 128.30, 126.26, 125.39, 123.47, 48.68, 40.25, 21.05.
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(S)-4-(4-oxo-4-phenylbutan-2-yl)benzonitrile (2k): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 4:1) and preparative
TLC (hexane/EtOAc, 4:1) the title compound was obtained as a white solid in 92% yield. The
spectroscopic data was consistent with the literature data, the absolute configuration was assigned
in comparison of the optical rotation reported and relative stereochemistry was assigned based on
the HPLC retention times reported in the literature.55 Enantiomeric excess was determined by
HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor = 18.6 min,
tminor 24.32 min; ee = 87% ee. [α]25D = +2.04 (c=1.10, CHCl3); 1HNMR (400 MHz, CDCl3) δ 7.81
– 7.69 (m, 8H), 7.67 – 7.54 (m, 8H), 7.54 – 7.40 (m, 12H), 7.39 – 7.32 (m, 8H), 3.49 (s, 3H), 3.17
(s, 3H), 2.87 (s, 3H), 1.44 – 1.31 (m, 12H); 13CNMR (100 MHz, CDCl3) δ 199.04, 152.37, 136.88,
133.24 – 133.03, 132.69, 128.83 – 128.45, 128.45 – 128.30, 126.61 – 126.40, 119.12, 106.7, 47.93,
38.80, 21.12.

(S)-1,3-diphenylpentan-1-one (2l): Following the general procedure for the reduction of α, βunsaturated enones, purification by column (hexane/EtOAc, 4:1) and preparative TLC
(hexane/EtOAc, 4:1) the title compound was obtained as a white solid for screening purposes. The
spectroscopic data was consistent with the literature data, the absolute configuration was assigned
in comparison of the optical rotation reported and relative stereochemistry was assigned based on
the HPLC retention times reported in the literature.56 Enantiomeric excess was determined by
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HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor = 5.454 min,
tminor = 6.427 min; S-enantiomer= 66% ee. [α]25D = +2.52 (c=0.97, CHCl3), literature value28 [α]RTD
= +2.49 (c=1.1, CHCl3) S-enantiomer= 89% ee; 1 HNMR (400 MHz, CDCl3): δ = 7.81-7.83 (m,
2H), 7.43-7.47 (m, 1H), 7.33-7.37 (m, 2H), 7.08-7.23 (m, 5H), 3.14-3.25 (m, 3H), 1.68-1.75 (m,
1H), 1.51-1.62 (m, 1H), 0.78 (t, 3H, J = 7.5 Hz); 13 CNMR (100 MHz, CDCl3): δ = 199.1, 144.6,
137.2, 132.9, 128.5, 128.4, 128.0, 127.6, 126.2, 45.7, 43.1, 29.3, 12.2.

(S)-4-methyl-1,3-diphenylpentan-1-one (2m): Following the general procedure for the reduction
of α, β-unsaturated enones, purification by column (hexane/EtOAc, 4:1) and preparative TLC
(hexane/EtOAc, 4:1) the title compound was obtained as a white solid for screening purposes. The
spectroscopic data was consistent with the literature data, the absolute configuration was assigned
in comparison of the optical rotation reported and relative stereochemistry was assigned based on
the HPLC retention times reported in the literature.57 Enantiomeric excess was determined by
HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor = 8.134 min,
tminor 9.715 min; S-enantiomer= 64% ee. [α]25D = +0.77 (c=1.09, CHCl3), literature value28 [α]RTD
= +0.75 (c=1.2, CHCl3) S-enantiomer= 97% ee; 1HNMR (400 MHz, CDCl3): δ = 7.86-7.89 (m,
2H), 7.50-7.54 (m, 1H), 7.40-7.43 (m, 2H), 7.23-7.27 (m, 2H), 7.13-7.19 (m, 3H), 3.66 (d, 2H, J
= 6.9 Hz), 3.14-3.20 (m, 1H), 1.90-2.00 (m, 1H), 0.99 (d, 3H, J = 6.6 Hz), 0.79 (d, 3H, J = 6.9 Hz);
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CNMR (100 MHz, CDCl3): δ = 199.3, 143.6, 137.3, 132.8, 128.4, 128.3, 128.0, 127.9, 126.1,

47.9, 42.6, 33.4, 21.1, 20.5.
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(S)-3-cyclohexyl-1,3-diphenylpropan-1-one (2n): Following the general procedure for the
reduction of α, β-unsaturated enones, purification by column (hexane/EtOAc, 4:1) and preparative
TLC (hexane/EtOAc, 4:1) the title compound was obtained as a white solid for screening purposes.
The spectroscopic data was consistent with the literature data and the absolute configuration was
assigned in comparison of the optical rotation with the literature value55 Enantiomeric excess was
determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor
= 10.650 min, tminor = 12.384 min; S-enantiomer= 34% ee. [α]25D = -0.89 (c=0.85, CHCl3), literature
value28 [α]RTD = +5.6 (c=1.4, CHCl3) R-enantiomer= 97% ee; 1HNMR (400 MHz, CDCl3): δ =
7.86-7.88 (m, 2H), 7.50-7.54 (m, 1H), 7.39-7.43 (m, 2H), 7.22-7.26 (m, 2H), 7.13-7.17 (m, 3H),
3.42 (dd, 1H, J = 5.5, 15.5 Hz), 3.30 (dd, 1H, J = 8.0, 16.5 Hz), 3.17-3.21 (m, 1H), 1.48-1.87 (m,
6H), 0.83-1.25 (m, 5H); 13 CNMR (100 MHz, CDCl3): δ = 199.4, 143.8, 137.3, 132.7, 128.4, 128.3,
128.0, 127.9, 126.0, 47.1, 43.2, 42.6, 31.5, 30.9, 26.7, 26.6, 26.5.

(S)-3-methyl-1,5-diphenylpentan-1-one (2p): Following the general procedure for the reduction
of α, β-unsaturated enones, purification by column (hexane/EtOAc, 4:1) and preparative TLC
(hexane/EtOAc, 4:1) the title compound was obtained as a white solid for screening purposes. The
spectroscopic data was consistent with the literature data, the absolute configuration was assigned
in comparison of the optical rotation reported and relative stereochemistry was assigned based on
the HPLC retention times reported in the literature.55 Enantiomeric excess was determined by
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HPLC with a Chiralcel AD-H column (hexane/iPrOH = 99.5/0.5, 1.0 mL/min), tmajor = 10.941 min,
tminor = 12.591 min; S-enantiomer= 56%. [α]25D = +6.7 (c=1.0, CHCl3), literature value28 [α]RTD =
+7.1 (c=1.1, CHCl3) S-enantiomer= 81% ee; 1 HNMR (400 MHz, CDCl3): δ = 7.92-7.94 (m, 2H),
7.53-7.57 (m, 1H), 7.43-7.47 (m, 2H), 7.26-7.29 (m, 2H), 7.15-7.19 (m, 3H), 3.00 (dd, 1H, J = 4.5,
15.9 Hz), 2.81 (dd, 1H, J = 7.9, 15.9 Hz), 2.61-2.76 (m, 2H), 2.24-2.26 (m, 1H), 1.70-1.77 (m, 1H),
1.56-1.63 (m, 1H), 1.03 (d, 3H, J = 6.4 Hz); 13CNMR (100 MHz, CDCl3): δ = 200.0, 142.4, 137.3,
132.9, 128.9, 128.5, 128.4, 128.3, 128.1, 125.7, 46.0, 39.0, 33.6, 29.7, 20.1.
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Chapter 3 Boro-phosphate catalyzed asymmetric reductive aldol
3.1 Background
The use of tandem reactions is a highly efficient method in the synthesis of organic
compounds.58,59 Methodologies that require multiple steps of reactions followed by
purifications, reduce the efficiency of the reaction and increase the amount of time spent on
purification and isolation of intermediates. Favorable tandem reactions would eliminate
excessive use of reagents and solvents, making the reactions much more cost effective.
Optically active tertiary alcohols are important building blocks found in both
naturally occurring and synthetic biologically active molecules.60-62 Developing reactions
that can accomplish the formation of these moieties enantioselectively would find great use
in the synthesis of pharmaceuticals. The aldol reaction is an example of a simple and efficient
reaction that can provide access to tertiary alcohols starting from a ketone.63,64 The
asymmetric reductive aldol reaction of α,β-unsaturated carbonyl compounds is an efficient
tandem reaction which provides access to optically active tertiary alcohols.65 In the past,
chiral catalysts with transition-metals such as boron and silane have been used to control the
stereochemistry of these transformations.66,67 Although boron enolates are known to be
remarkably useful intermediates for asymmetric aldol reactions, these reactions are still
limited by the reactivity of the ketone.68,69

46

3.2 Methodology
In synthetic organic chemistry, several methodologies that use organoboron compounds
have been developed for carbon–carbon bonds.70,71 Organoboron compounds are touted as being
a safer, environmentally-friendly alternative to organometallic reagents. Organometallic reagents
produce toxic byproducts72 which at times are difficult to remove from the reaction mixture
whereas boric acid is the primary byproduct in reactions using organoboron reagents. Similarly,
their versatility have made them one of the most widely utilized reagents in aldol additions73,74,
aldol condensations75,76 and coupling reactions77,78 to name a few.
Since the early 1980s, boron enolates79 have been a major component in the aldol
condensation reaction and the stereochemical control of the reaction has been in extensively
studied.

Figure 23. Stereochemical preferences of the (E)- and (Z)-enolate in the aldol reaction

The reaction has been found to proceed via a Zimmerman-Traxler model80, six-membered, chair
like transition state with the stereochemical outcome being dependent on the configuration of the

47

enolate. The high stereochemical control observed for boron-mediated aldol reactions, is attributed
to the short bond length between the B-O (1.4-1.5Å) bond which allows for a tighter transition
state that produces syn-aldol product for the (Z)-enolates and anti-aldol product for the (E)enolate.81
Guided by the results that were obtained from the boro-phosphate catalyzed reduction, we
proceeded to examine introduction of benzaldehyde as the electrophile after formation of the boron
enolate. Once the preceding phosphoboronate-catalyzed 1, 4-addition of the hydride takes place,
3.3 Results and Discussion
Having obtained successful results using the chiral BINOL-derived boro-phosphate
catalyst to enantioselectively reduce of α, β-unsaturated enones to the corresponding ketone
substrates, we were interested in expanding the utility of this transformation.

Figure 24. Proposed mechanism of reductive aldol

By adding the electrophile to the boron enolate (figure 25) formed in the reaction, it would be
possible to use the stereocenter set when the hydride attacks at the β-position, can potentially
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influence the facial selectivity of the reaction (figure 21). Furthermore, the (Z)-enolate that is
formed in the reduction step would preferentially give the syn-aldol product. With this information
it would be possible to determine the overall relative stereochemistry of the synthesized
compounds.
Table 10. Reductive aldol substrate scope

Being that the reaction conditions used in the secondary reaction would be the same used
in the initial reduction, we used the substrates with the best results for the reduction for the aldol
(table 10). The reaction proceeded smoothly at room temperature to give the 1,4-reduced product
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as expected giving full conversion observed by TLC and 1H NMR in 24 hours using anhydrous
cyclohexane as the solvent (table 10). Keeping the reaction under argon, benzaldehyde was then
added to the reaction mixture. The diastereomeric ratios for the selected substrates showed
excellent selectivity (up to 99% ee). The substrate that showed lowest selectivity compared to the
other substrates examined was substrate 2b, but still showed high selectivity (table 10, entry 2).
Overall, we were pleased to see that the results were as what were what we had expected, giving
high enantioselectivity for the both the major and the minor diastereomers, with the exception
being table 10, entry 2. For this case, the enantioselectivity of the minor enantiomer was only 52%.
The substrates that had strong electron withdrawing substituents (table 10, entry 3) as well as weak
electron withdrawing substituents (table 10, entry 6) gave the highest enantioselectivities for both
the major and the minor diastereomer with very high diastereoselectivity (table 10, entry 3, and
66:1 dr) and (table 10, entry 6, 99:1 dr). Overall, the stereospecificity of the boron-mediated aldol
in conjunction with the high enantioselectivity of the reduction step, would allow for the formation
of three stereocenters with excellent enantioselectivity and diastereoselectivity.
3.4 Summary
The aldol reaction is one of the most well-known and used reactions in organic synthesis.
Due its great synthetic utility and atom economy, the aldol reaction has assisted in the design and
development of chiral catalysts. The use of a one-pot method to achieve an enantioselective tandem
reaction is synthetically beneficial to assemble optically active tertiary alcohols. Using our borophosphate catalyzed 1,4-reduction of α, β-unsaturated enones methodology, we were able to
sequentially react the enolate intermediate with benzaldehyde and obtain the aldol product. The
reductive aldol products were obtained in good to excellent diastereomeric ratios (up to 99:1 dr).
Further investigations are underway in order to provide stereochemical evidence and mechanistic
rational.
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3.5 Experimental
3.5.1 General considerations
Unless otherwise noted, all reactions were carried out in flame-dried screw-cap test tubes
and were allowed to proceed under a dry argon atmosphere with magnetic stirring. Anhydrous
solvents were purchased from commercial sources and used without further purification. Ketones
were purchased from commercial sources and used without further purification. PA catalysts were
prepared from chiral BINOL according to the known literature procedure.46 Thin layer
chromatography was performed on Merck TLC plates (silica gel 60 F254). Ketones were purchased
from commercial sources without any further purification. Thin layer chromatography was
performed on Merck TLC plates (silica gel 60 F254). Visualization was accomplished using UV
light (256 nm), p-anisaldehyde or potassium permanganate stain as indicator. Flash column
chromatography was performed with Merck silica gel (230-400 mesh). Analytical Autopol IV
polarimeter (589) using a 700-µL cell with a path length of 1-dm. 1H NMR and 13C NMR were
recorded on a Varian Inova-400 spectrometer with chemical shifts reported relative to
tetramethylsilane (TMS). Data were recorded as follows: chemical shift in ppm from internal
tetramethylsilane on the G scale, multiplicity (s = singlet; d = doublet; t = triplet; q = quartet; m =
multiplet; br = broad), coupling constant (Hz), integration, and assignment. All the compounds
were known compounds and were characterized by comparing their 1H NMR and 13C NMR values
those reported in the literature. Enantioselectivity was determined using a Varian Prostar HPLC
and Chiralcel AD-H, OD-H, or AS-H chiral columns. All reactions were conducted in triplicate to
ascertain reproducibility.
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Compound (3.2a):
(2R, 3R)-2-((R)-hydroxy (phenyl) methyl)-1, 3-diphenylbutan-1-one
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH =
96/4, 0.8 mL/min), tR = 18.51 min (anti, major), 27.18 min (syn, major), 34.87 min (syn, minor),
42.98 min (anti, minor). 1HNMR (400 MHz, CDCl3): δ 7.83 (dd, J = 7.4, 1.4 Hz, 2H), 7.47 – 7.24
(m, 11H), 7.24 – 7.14 (m, 2H), 5.84 (d, J = 10.6 Hz, 1H), 3.66 (dd, J = 10.8, 2.2 Hz, 1H), 3.29 (qd,
J = 6.5, 2.1 Hz, 1H), 1.37 (d, J = 6.6 Hz, 3H), 1.28 (s, 1H).

13

C NMR (100 MHz, CDCl3) δ 206.28,

144.55, 142.77, 136.46, 132.13, 128.53, 128.40, 128.19, 128.05, 127.98, 127.77, 127.43, 126.03,
74.20, 54.88, 39.57, 20.60.

Compound (3.2b):
(2R, 3R)-2-((R)-hydroxy (phenyl) methyl)-3-(naphthalen-2-yl)-1-phenylbutan-1-one
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH =
96/4, 0.8 mL/min), tR = 18.83 min (anti, major), 11.89 min (syn, major), 16.61 min (syn, minor),
8.93 min (anti, minor). 1HNMR (400 MHz, CDCl3): δ 7.85 – 7.64 (m, 6H), 7.45 – 7.15 (m, 11H),
5.42 (d, J = 10.1 Hz, 1H), 3.66 (dd, J = 10.0, 5.9 Hz, 1H), 3.31 (p, J = 6.5 Hz, 1H), 1.45 (s, 1H),
1.37 (d, J = 6.4 Hz, 3H). 13CNMR (100 MHz, CDCl3) δ 206.30, 146.09, 143.12, 137.01, 134.98,

52

133.83, 132.13, 129.73, 128.53, 128.46, 128.40, 128.19, 128.11, 127.77, 127.43, 126.92, 126.47,
125.11, 123.24, 73.98, 54.96, 39.64, 20.61.

Compound (3.2c):
(2R, 3R)-2-((R)-hydroxy (phenyl)methyl)-1-phenyl-3-(4-(trifluoromethyl)phenyl)butan-1-one
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH =
96/4, 0.8 mL/min), tR = 19.287 min (anti, major), 26.697 min (syn, major), 32.304 min (syn,
minor). 1HNMR (400 MHz, CDCl3): δ 7.76 (dd, J = 7.5, 1.2 Hz, 2H), 7.37 – 7.18 (m, 9H), 7.73 –
5.55 (m, 13H), 7.37 – 5.55 (m, 10H), 5.65 (d, J = 1.6 Hz, 1H), 4.43 (s, 1H), 3.66 (t, J = 1.5 Hz,
1H), 3.14 (qd, J = 6.4, 1.5 Hz, 1H), 1.36 (d, J = 6.5 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 206.28,
146.57, 142.77, 136.46, 132.35, 132.13, 131.91, 131.70, 128.53, 128.40, 128.19, 127.77, 127.60,
127.43, 127.07, 127.04, 127.00, 126.97, 126.27, 126.21, 126.15, 126.10, 125.51, 123.41, 121.36,
74.16, 54.92, 39.84, 20.57.

Compound (3.2d):
(2R,3R)-2-((R)-hydroxy(phenyl)methyl)-3-(4-methoxyphenyl)-1-phenylbutan-1-one
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH =
96/4, 0.8 mL/min), tR = 37.46 min (anti, major), 32.34 min (syn, major), 26.78 min (syn, minor),
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22.06 min (anti, minor). 1HNMR (400 MHz, CDCl3): δ 7.81 (dd, J = 7.4, 1.3 Hz, 2H), 7.48 – 7.27
(m, 5H), 7.27 – 7.11 (m, 5H), 6.99 (d, J = 7.5 Hz, 2H), 5.55 (d, J = 9.2 Hz, 1H), 3.80 (s, 3H), 3.66
(dd, J = 12.1, 9.2 Hz, 1H), 3.12 (dq, J = 12.8, 6.5 Hz, 1H), 1.30 (d, J = 6.6 Hz, 3H), 0.30 (s, 1H).
13

C NMR (125 MHz, CDCl3) δ 206.28, 157.06, 142.77, 136.72, 136.46, 132.13, 128.53, 128.40,

128.19, 127.77, 127.57, 127.43, 114.04, 74.20, 56.10, 54.99, 39.57, 20.60.

Compound (3.2e):
(2R,3R)-1-(4-fluorophenyl)-2-((R)-hydroxy(phenyl)methyl)-3-phenylbutan-1-one
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH =
96/4, 0.8 mL/min), tR = 7.018 min (anti, major), 10.226 min (syn, major), 13.320 min (syn, minor),
16.172 min (anti, minor). 1HNMR (400 MHz, CDCl3): 1H NMR (400 MHz, CDCl3) δ 7.67 – 7.58
(m, 2H), 7.34 – 6.53 (m, 12H), 5.31 (d, J = 1.8 Hz, 1H), 3.66 (dd, J = 4.1, 1.9 Hz, 1H), 3.43 (qd, J
= 6.6, 4.1 Hz, 1H), 1.87 (s, 1H), 1.41 (d, J = 6.6 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 217.91,
206.28, 167.86, 165.77, 144.55, 142.77, 133.64, 133.61, 130.88, 130.82, 128.19, 128.05, 127.98,
127.77, 127.43, 126.03, 115.05, 114.84, 74.20, 54.96, 39.52, 20.59.
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Compound (3.2f):
(2R,3R)-3-(4-chlorophenyl)-2-((R)-hydroxy(phenyl)methyl)-1-phenylbutan-1-one
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column (hexane/iPrOH =
96/4, 0.8 mL/min), tR = 37.458 min (anti, major), 32.373 min (syn, major), 26.781 min (syn,
minor), 22.056 min (anti, minor). 1HNMR (400 MHz, CDCl3): δ 8.66 – 5.50 (m, 15H), 5.53 (d, J
= 1.6 Hz, 1H), 5.53 (d, J = 1.6 Hz, 1H), 3.66 (d, J = 1.3 Hz, 1H), 3.40 (q, J = 6.4 Hz, 1H), 1.87 (s,
1H), 1.42 (d, J = 6.6 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 206.20, 142.80, 142.62, 135.98,
132.13, 131.69, 129.20, 128.52, 128.40, 128.19, 128.17, 127.77, 127.43, 74.20, 54.96, 39.57, 20.59.
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Appendix I
Preparation and characterization of catalysts
General Considerations
All reactions involving air or moisture sensitive reagents were performed under an argon in flamedried glassware using standard syringe, cannula, or Schlenk techniques. Anhydrous
tetrahydrofuran (THF), diethyl ether (Et2O) and dichloromethane (CH2Cl2) were purchased from
commercial sources and used without purification, unless otherwise stated. Prior to use, the
potassium carbonate (K2CO3) was flame dried to remove moisture. Chloromethyl methyl ether was
prepared according to the literature.82

(R)-BINOL and (S)-BINOL were purchased from

commercial sources without any further purification. Thin layer chromatography was performed
on Merck TLC plates (silica gel 60 F254). Visualization was accomplished using UV light (256
nm), p-anisaldehyde or potassium permanganate stain as indicator. Flash column chromatography
was performed with Merck silica gel (230-400 mesh). Analytical Autopol IV polarimeter (l589)
using a 700-µL cell with a path length of 1-dm. 1H NMR and 13C NMR were recorded on a Varian
Inova-400 spectrometer with chemical shifts reported relative to tetramethylsilane (TMS). Data
were recorded as follows: chemical shift in ppm from internal tetramethylsilane on the G scale,
multiplicity (s = singlet; d = doublet; t = triplet; q = quartet; m = multiplet; br = broad), coupling
constant (Hz), integration, and assignment. All the compounds were known compounds and were
characterized by comparing their 1H NMR and 13C NMR values those reported in the literature.
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Synthesis of (R) 2,2'-bis(methoxymethoxy)-1,1'-binaphthalene:

(R)-2,2'-bis(methoxymethoxy)-1,1'-binaphthalene

was

prepared

according

to

literature

procedures.83

Synthesis of 3,3'-diiodo-2,2'-bis(methoxymethoxy)-1,1'-binaphthalene: To a stirred solution of
2,2'-bis(methoxymethoxy)-1,1'-binaphthalene (17 mL/1 mmol) suspended in anhydrous Et2O (20
mL) at -78 °C was added a solution of n-butyllithium (2.52 M in hexanes; 3 equiv.) and was stirred
for 1 h. The mixture was then allowed to warm to room temperature and stirred for 3 h at which
point the reaction mixture was re-cooled to -78 °C and iodine (3 equiv.) as a solid was added in
one portion. The reaction mixture was stirred for 1 h then allowed to warm slowly to room
temperature over four hours. Saturated aqueous ammonium chloride (40 mL) was added to the
reaction mixture and the organic and aqueous phases separated. The aqueous phase was extracted
with ethyl acetate (3 x 30 mL) and the combined organic phases were then washed with aqueous
sodium sulfite (10 percent w/v; 30 mL), de-ionized water (10 mL) and brine (10 mL). The organic
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layers were then dried over anhydrous sodium sulfate and dried in vacuo. The residue was purified
by flash column chromatography (15:1 =silica gel/material, 15:1 hexane/EtOAc). The eluent was
collected in Fisherbrand™ disposable borosilicate glass tubes with plain end (Cat. No. 14-961-29
16x100mm) and the corresponding fractions were visualized by TLC using UV light (256 nm).
The fractions containing the desired product were then collected were concentrated in vacuo.

General procedure for the synthesis of 3,3'-Diaryl-2,2'-Bis(methoxymethoxy)-1,1'binaphthyls: A mixture of DME (6.7mL/mmol) and 2M Na2CO3 (5.2 equiv.) was degassed with
argon for 30 minutes prior to use in the reaction. The aryl boronic acid (3.5 equiv.), 3, 3'-diiodo-2,
2'-bis (methoxymethoxy)-1,1'-binaphthalene (1 equiv.), and tetrakis (triphenylphosphine)
palladium (0) (1 mol%) were placed in a flame dried reaction flask. The degassed solvents were
added to the mixture of solids via cannula, the reaction mixture was heated to reflux and monitored
by TLC (1:1 DCM/hexane). Upon completion, the reaction mixture was allowed to cool to room
temperature, diluted with DCM. Saturated aqueous ammonium chloride (40 mL) was added to the
reaction mixture and the organic and aqueous phases separated and the washed brine (2 x 10 mL).
The organic phase was dried over Na2SO4 and concentrated in vacuo. The crude product was
purified by column chromatography (15:1 silica gel/material, 1:1 DCM/hexane). The eluent was
collected in Fisherbrand™ disposable borosilicate glass tubes with plain end (Cat. No. 14-961-29
16x100mm) and the corresponding fractions were visualized by TLC using UV light (256 nm).
The fractions containing the desired product were then collected were concentrated in vacuo to
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give a light yellow solid in 98% yield. The spectroscopic data was in agreement with the reported
literature values.84

Synthesis of 3,3'-diaryl-[1,1'-binaphthalene]-2,2'-diol:
The (2,2'-bis(methoxymethoxy)-[1,1'-binaphthalene]-3,3'-diyl) diaryl (1 equiv.) was suspended in
a 2:1 MeOH/toluene solution. To the mixture was added 12N HCl (8.45 equiv.) and let stir for 6
hours a reflux. The reaction was diluted with EtOAc and organic phase was dried over Na2SO4
and concentrated in vacuo. The product was used in the next step without further purification.

Synthesis of 2,6-diaryl-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide:
The 3, 3’-diaryl-[1, 1’-binaphthalene]-2, 2’-diol (1 equiv.) was suspended in pyridine
(2.56mL/mmol) under argon. The reaction was cooled to 0oC and phosphorous oxychloride (2
equiv.) was added slowly dropwise at room temperature while stirring [CAUTION: Phosphorus
oxychloride may ignite other combustible materials (wood, paper, oil, etc.). Phosphorus
oxychloride reacts violently with water]. The suspension was heated to 95 ºC for 12h hours and
the let cool to room temperature, then cooled to 0oC. Deionized water (2 mL) was then added to
the reaction mixture and the solution heated to 100 ºC for 1 hour. Once again, the reaction was
cooled to room temperature. DCM was used to extract the organic layer (3 x 30 mL) and the
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combined organic phases were then washed de-ionized water (10 mL) and brine (10 mL), and the
pyridine was removed by washing with 6N HCl (10 mL). The organic phase was dried over
Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography
(15:1= silica gel/material, 98.5:1.5 DCM/MeOH). The eluent was collected in Fisherbrand™
disposable borosilicate glass tubes with plain end (Cat. No. 14-961-29 16x100mm) and the
corresponding fractions were visualized by TLC using UV light (256 nm). The fractions containing
the desired product were then collected were concentrated in vacuo. 1HNMR was used to
determine the compounds isolated in the fractions. The product obtained was re-acidified by
dissolving the solid in DCM and extracting the organic phase (3 x 10 mL) with 6N HCl. The
combined aqueous layers were then washed with DCM (3 x 10 mL). The organic phase was dried
over Na2SO4 and concentrated in vacuo.

67

Appendix II
Preparation and characterization of reaction substrates
General Considerations
Unless otherwise noted, all reactions were carried out under argon atmosphere in flame-dried
glassware using standard syringe, cannula, and septa apparatus. Prior to use, the K2CO3 was flame
dried to remove moisture. Anhydrous solvents and reagents were purchased from commercial
sources and used without purification, unless otherwise stated. Ketones were purchased from
commercial sources without any further purification. Thin layer chromatography was performed
on Merck TLC plates (silica gel 60 F254). Visualization was accomplished using UV light (256
nm), ceric ammonium molybdate, p-anisaldehyde, or potassium permanganate or as indicator.
Flash column chromatography was performed with Merck silica gel (230-400 mesh). 1H NMR and
13

C NMR were recorded on a Varian Inova-400 spectrometer with chemical shifts reported relative

to tetramethylsilane (TMS). Data were recorded as follows: chemical shift in ppm from internal
tetramethylsilane on the G scale, multiplicity (s = singlet; d = doublet; t = triplet; q = quartet; m =
multiplet; br = broad), coupling constant (Hz), integration, and assignment. All the compounds
were known compounds and were characterized by comparing their 1H NMR and 13C NMR values
those reported in the literature.
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General procedure for the synthesis of ethyl esters

To a flame dried flask with magnetic stirrer was added sodium hydride (NaH) 60%
dispersion in mineral oil [CAUTION: Upon reaction of sodium hydride dispersion with water, H2
and NaOH are formed. This hydrolysis reaction is vigorous and exothermic] (1.75 equiv.) in
anhydrous THF (12mL). The solution was cooled to 0oC and the triethyl phosphonoacetate (1.5
equiv.) was added slowly dropwise. The mixture was stirred at 0oC for 30 minutes. The ketone
was then added and the mixture and was allowed to reflux, while monitored by TLC
(hexanes/EtOAc 20:1). Upon completion, the reaction was quenched with a solution of saturated
aqueous NaHCO3 (100 mL) was added and the aqueous layer was extracted with EtOAc (3 x 100
mL). The combined organic layer was washed with brine (100 mL), dried with anhydrous Na2SO4
and concentrated in vacuo. The crude product was then purified by flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The eluent was collected in
Fisherbrand™ disposable borosilicate glass tubes with plain end (Cat. No. 14-961-29 16x100mm)
and the corresponding fractions collected were concentrated in vacuo to give the desired ethyl ester.
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Ethyl (E/Z) 3-phenylbut-2-enoate (1aa): Following the general procedure for the synthesis of
ethyl esters, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a pale yellow oil in 93 % yield.
The spectroscopic data was consistent with the literature.28 E-isomer: 1 H NMR (400 MHz, CDCl3),
δ 7.44 (m, 2 H), 7.33 (m, 3 H), 6.12 (s, 1 H), 4.19 (q, J = 7.1 Hz, 2 H), 2.56 (s, 3 H), 1.29 (t, J =
7.1 Hz, 3 H); 13C NMR (100 MHz, CDCl3), δ 166.8, 155.4, 142.1, 128.9, 128.4, 126.2, 117.0, 59.7,
17.8, 14.2; HRMS calculated for [M + H]+C12H15O2, 191.1072; found, 191.1065. Z-isomer: 1 H
NMR (400 MHz, CDCl3), δ 7.3 (m, 3 H), 7.18 (d, J = 6.0 Hz, 2 H), 5.89 (s, 1 H), 3.97 (q, J = 7.1
Hz, 2 H), 2.15 (s, 3 H), 1.06 (t, J = 7.1 Hz, 3 H).

ethyl (E)-3-(naphthalen-2-yl) but-2-enoate (1ab): Following the general procedure for the
synthesis of ethyl esters, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless oil, yield 97%. The
spectroscopic data was consistent with the literature.85 1HNMR (400 MHz, CDCl3): d 7.93–7.79
(m,4H), 7.60–7.56(m,1H),7.50–7.45 (m, 2H), 6.28 (s, 1H), 4.27–4.20 (q,2H, J = 7.2 Hz), 2.68 (s,
3H), 1.35–1.30 (t, 3H, J =7.2Hz);13C MR(100 MHz, CDCl3): d 155.7, 139.9, 134.0, 133.6, 129.0,
128.7, 128.1, 127.2, 127.0, 126.4, 124.5, 118.0, 60.4, 18.4, 14.9. HRMS calcd for
[M + H]+ C16H17O2, 241.1228; found, 241.1230.
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ethyl (E)-3-(naphthalen-1-yl)but-2-enoate (1ac): Following the general procedure for the
synthesis of ethyl esters, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless oil, yield 97%. The
spectroscopic data was consistent with the literature.86 1HNMR (400 MHz, CDCl3): δ 7.93 (dt, J =
7.3, 1.4 Hz, 1H), 7.89 – 7.72 (m, 2H), 7.68 (dd, J = 7.4, 1.5 Hz, 1H), 7.60 (t, J = 7.5 Hz, 1H), 7.51
– 7.41 (m, 2H), 6.54 (d, J = 0.6 Hz, 1H), 4.24 (q, J = 6.0 Hz, 2H), 2.23 (d, J = 0.6 Hz, 3H), 1.39
(t, J = 6.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 168.22, 153.26, 138.95, 131.85, 128.59, 128.33,
127.64, 125.95, 125.55, 125.31, 124.31, 121.97, 118.23, 61.16, 18.26, 14.69.

ethyl (E)-3-(4-methoxyphenyl)but-2-enoate (1ad): Following the general procedure for the
synthesis of ethyl esters, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless oil, yield 80%. The
spectroscopic data was consistent with the literature.87 1HNMR (400 MHz, CDCl3): d 7.43–7.46(m,
2H), 6.87–6.90 (m, 2H), 6.10–6.11 (d, 1H, J = 1.2 Hz), 4.17–4.24(q, 2H, J = 7.2 Hz), 3.81 (s, 3H),
2.56 (d, 3H, J = 1.2 Hz ), 1.28–1.33 (t,3H, J = 7.2Hz);13C-NMR (100 MHz, CDCl3): d 167.5,
160.9, 155.3,134.8, 128.1, 115.8, 114.3, 60.2, 55.8, 18.1, 14.9; HRMS calcd for
[M + H]+ C13H17O3, 221.1177; found, 221.1179.
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ethyl (E)-3-(4-fluorophenyl)but-2-enoate (1ae): Following the general procedure for the
synthesis of ethyl esters, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless oil in 80% yield.
The spectroscopic data was consistent with the literature.88 1HNMR (400 MHz, CDCl3): d 7.44–
7.48(m, 2H), 7.02–7.08 (m, 2H), 6.09 (d, 1H, J = 1.2 Hz), 4.18–4.25 (q,2H, J = 7.2 Hz), 2.55–2.56
(d, 3H, J = 1.2 Hz), 1.29–1.34 (t, 3H,J = 7.2 Hz);13CNMR (100 MHz, CDCl3): d 167.2, 165.4,
162.1,154.7, 138.7, 128.6, 117.6, 60.4, 18.4, 14.8; HRMS calcd for [M + H]+ C12H14FO2 209.0971;
found, 209.0969.

ethyl (E)-3-(4-(trifluoromethyl)phenyl)but-2-enoate (1af): Following the general procedure for
the synthesis of ethyl esters, purification flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless oil, yield 96%.
The spectroscopic data was consistent with the literature.89 1HNMR (400 MHz, CDCl3): d 7.55–
7.64 (m,4H), 6.15 (d, 1H, J = 1.5 Hz), 4.20–4.27 (q, 2H, J = 7.2 Hz), 2.58 (d, 3H,J =1.2Hz ), 1.30–
1.35 (t, 3H, J =7.2Hz);13CNMR (100MHz, CDCl3): d166.9, 154.2, 146.3, 127.1, 126.2, 125.9,
122.6, 119.5, 60.6, 18.4,14.8; HRMS calcd for [M + H]+ C13H14F3O2, 259.0936; found, 259.0932.
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ethyl (E)-3-(4-chlorophenyl)but-2-enoate (1ag): Following the general procedure for the
synthesis of ethyl esters, purification by column chromatography flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
colorless oil, yield 82%. The spectroscopic data was consistent with the literature.90 1HNMR (400
MHz, CDCl3): d 7.32–7.42(m, 4H), 6.10–6.12 (q, 1H, J = 1.2 Hz), 4.18–4.25 (q, 2H, J = 7.2
Hz),2.55 (d, 3H, J = 1.2 Hz ), 1.29–1.34 (t, 3H, J = 7.2 Hz); 13CNMR (100 MHz, CDCl3): d 167.1,
154.5, 141.1, 135.5, 129.2, 128.1, 118.0,60.4, 18.3, 14.8; HRMS calcd for [M + H]+ C12H14ClO2,
225.0677; found, 225.0679.

ethyl (E)-3-(4-cyanophenyl)but-2-enoate (1ah): Following the general procedure for the
synthesis of ethyl esters, purification by column chromatography flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
colorless oil, yield 51%. The spectroscopic data was consistent with the literature.91 1HNMR (400
MHz, CDCl3): δ = 7.68 – 7.64 (m, 2H), 7.56 – 7.53 (m, 2H), 6.14 (q, J = 1.3 Hz, 1H), 4.22 (q, J =
7.1 Hz, 2H), 2.55 (d, J = 1.3 Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3):
δ = 166.3, 153.1, 146.8, 132.5, 127.1, 119.8, 118.6, 112.6, 60.4, 17.9, 14.4.

ethyl (E)-3-phenylpent-2-enoate (1ai): Following the general procedure for the synthesis of ethyl
esters, purification by flash column chromatography (silica gel/material =15:1, hexanes/EtOAc =
30:1→10:1). The title compound was obtained as a colorless oil, yield 92%. The spectroscopic
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data was consistent with the literature.

92 1

HNMR (400 MHz, CDCl3): δ = 7.48 – 7.33 (m, 5H),

6.01 (s, 1H), 4.21 (q, J = 7.1 Hz, 2H), 3.11 (q, J = 7.5 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H), 1.08 (t, J
= 7.5 Hz, 3H) ppm; 13CNMR (100 MHz, CDCl3): δ = 166.6, 162.2, 141.3, 129.0, 128.6, 126.8,
116.9, 60.0, 24.5, 14.5, 13.7.

ethyl (E)-4-methyl-3-phenylpent-2-enoate (1aj): Following the general procedure for the
synthesis of ethyl esters, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless oil, yield 86%. The
spectroscopic data was consistent with the literature.93 1HNMR (400 MHz, CDCl3): δ 7.35 – 7.28
(m, 3H), 7.22 – 7.18 (m, 2H), 5.70 (s, 1H), 4.20 (q, J = 7.1 Hz, 2H), 4.16 – 4.06 (m, 1H), 1.30 (t,
J = 7.1 Hz, 3H), 1.09 (d, J = 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3): δ = 167.2, 166.4, 140.9,
127.9, 127.8, 127.7, 118.7, 60.0, 29.7, 21.5, 14.4.

ethyl (E)-3-cyclohexyl-3-phenylacrylate (1ak): Following the general procedure for the
synthesis of ethyl esters, purification by column chromatography flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
colorless oil, yield 33%. The spectroscopic data was consistent with the literature.94 1HNMR (400
MHz, CDCl3): δ 7.37 – 7.28 (m, 3H), 7.12 – 7.05 (m, 2H), 5.83 (d, J = 1.0 Hz, 1H), 3.95 (q, J =
7.1 Hz, 2H), 2.31 – 2.18 (m, 1H), 1.86 – 1.72 (m, 4H), 1.33 – 1.08 (m, 6H), 1.03 (t, J = 7.1 Hz,
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3H); 13CNMR (100 MHz, CDCl3): δ 166.7, 164.6, 140.7, 127.8, 127.3, 127.3, 116.1, 59.8, 47.5,
31.7, 26.6, 26.2, 14.0.

ethyl (E)-3,4,4-trimethylpent-2-enoate (1al): Following the general procedure for the synthesis
of ethyl esters, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless oil, yield 70%. The
spectroscopic data was consistent with the literature.95 1HNMR (400 MHz, CDCl3): δ = 5.73 (q, J
= 1.2 Hz, 1H), 4.15 (q, J = 7.2 Hz, 2H), 2.16 (d, J = 1.2 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H), 1.10 (s,
9H); 13CNMR (100 MHz, CDCl3): δ 167.7, 167.4, 113.1, 59.7, 38.1, 28.7, 15.3, 14.5.

ethyl (E)-3-methyl-5-phenylpent-2-enoate (1am): Following the general procedure for the
synthesis of ethyl esters, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless oil, yield 94%. The
spectroscopic data was consistent with the literature.96 1HNMR (400 MHz, CDCl3): δ 7.31 (m, 2H);
7.21 (m, 3H); 5.71 (m, 1H); 4.16 (q, 2H, J = 7.1 Hz); 2.80 (m, 2H); 2.46 (m, 2H); 2.23 (d, 3H, J =
1.2 Hz); 1.29 (t, 3H, J = 7.1 Hz); 13C NMR (100 MHz, CDCl3): δ 166.7, 158.9, 141.0, 128.4, 128.2,
126.0, 115.9, 59.4, 42.6, 33.9, 18.9, 14.3; HRMS calculated for C14H19O2, 219.1402, found
219.1399.
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Synthesis of Weinreb amides

To a flame dried flask with magnetic stirrer was added N, O-dimethylhydroxyamine HCl
(2 equiv.) suspended in anhydrous THF (12mL). The ester obtained from reaction 1 (1 equiv.) was
added and the mixture was cooled to -5oC. Once cooled, i-PrMgCl (4.3 equiv.) [CAUTION:
Flammable liquid. Water reactive. In case of fire, do not use water or carbon dioxide] was slowly
added dropwise and the reaction was allowed to stir and monitored by TLC (hexanes/EtOAc 20:1)
until completion. Saturated aqueous ammonium chloride (40 mL) was added to the reaction
mixture and the organic and aqueous phases separated. The aqueous phase was extracted with
ethyl acetate (3 x 30 mL) and the combined organic phases were then dried over anhydrous sodium
sulfate and the solvent was evaporated in vacuo. The crude product was then purified by flash
column chromatography (silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The eluent was
collected in Fisherbrand™ disposable borosilicate glass tubes with plain end (Cat. No. 14-961-29
16x100mm) and the corresponding fractions collected were concentrated in vacuo to give the
desired Weinreb amide.
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(E)-N-methoxy-N-methyl-3-phenylbut-2-enamide (1ba): Following the general procedure for
the synthesis of Weinreb amides, purification flash column chromatography (silica gel/material
=15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a pale yellow liquid,
98%. The spectroscopic data was consistent with the literature.97 1H NMR (CDCl3, 400 MHz):
δ=7.51-7.45 (m, 2H), 7.41-7.33 (m, 3H), 6.57 (s, 1H), 3.71 (s, 3H), 3.27 (s, 3H), 2.51 ppm (d, J=1
Hz, 3H); 13C NMR (CDCl3, 100 MHz): δ=168.0, 152.3, 143.0, 128.6, 128.5, 126.3, 116.0, 61.6,
32.4, 18.0. HRMS calculated for C12H15NO2, 235.1208, found 235.1214.

(E)-N-methoxy-N-methyl-3-(naphthalen-2-yl) but-2-enamide (1bb): Following the general
procedure for the synthesis of Weinreb amides, purification by flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
pale yellow liquid, 99% yield. The spectroscopic data was consistent with the literature.93 1HNMR
(400 MHz, CDCl3) δ 7.91 (s, 1H), 7.85-7.78 (m, 3H), 7.59 (d, J = 11.2 Hz, 1H), 7.49-7.42 (m, 2H),
6.72 (s, 1H), 3.68 (s, 3H), 3.27 (s, 3H), 2.64 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 164.61,
147.28, 139.74, 134.51, 134.01, 129.74, 129.69, 128.21, 126.99, 126.50, 124.13, 123.41, 122.90,
57.58, 34.18, 18.05. HRMS calculated for C16H17NO2: 255.1258, found 255.1263.
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(E)-N-methoxy-N-methyl-3-(naphthalen-1-yl) but-2-enamide (1bc): Following the general
procedure for the synthesis of Weinreb amides, purification by flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
pale yellow liquid, 61% yield. The spectroscopic data was consistent with the literature.98 1H NMR
(400 MHz, CDCl3) δ 7.97-7.94 (m, 1H), 7.85-7.83 (m, 1H), 7.79-7.76 (m, 1H), 7.48-7.41 (m, 3H),
7.31-7.29 (m, 1H), 6.42 (s, 1H), 3.63 (s, 3H), 3.27 (s, 3H), 2.60 (s, 3H) ppm; 13C NMR (100 MHz,
CDCl3) δ 167.5, 153.6, 142.6, 133.6, 130.2, 128.3, 127.7, 126.0, 125.8, 125.3, 125.1, 124.1, 118.9,
61.4, 32.1, 21.4. HRMS calculated for C16H17NO2: 255.1259, found 255.1258.

(E)-N-methoxy-3-(4-methoxyphenyl)-N-methylbut-2-enamide (1bd): Following the general
procedure for the synthesis of Weinreb amides, purification by flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
pale yellow liquid, 89% yield. The spectroscopic data was consistent with the literature.98 1NMR
(400 MHz, CDCl3) δ 7.45 (dd, J = 6.4, 1.6 Hz, 2H), 6.90 (dd, J = 6.4, 1.6 Hz, 2H), 6.55 (s, 1H),
3.83 (s, 3H), 3.71 (s, 3H), 3.26 (s, 3H), 2.52 (d, J = 1.2 Hz, 3H) ppm; 13CNMR (100MHz, CDCl3)
δ 168.1, 160.0, 151.7, 135.0, 127.5, 114.1, 113.7, 61.5, 55.2, 32.1, 17.7. HRMS calculated for
C14H19NO3: 235.1208, found 235.1214.
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(E)-3-(4-fluorophenyl)-N-methoxy-N-methylbut-2-enamide (1be): Following the general
procedure for the synthesis of Weinreb amides, purification by flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
pale yellow liquid, 70% yield. The spectroscopic data was consistent with the literature.98 1HNMR
(400 MHz, CDCl3) δ 7.48-7.44 (m, 2H), 7.08-7.03 (m, 2H), 6.53 (s, 1H), 3.71 (s, 3H), 3.27 (s, 3H),
2.51 (d, J = 1.2 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 167.1, 162.3, 150.2, 138.3, 127.4,
115.4, 114.7, 60.9, 31.6, 17.3. HRMS calculated for C12H14FNO2, 239.0713, found 239.0717.

(E)-N-methoxy-N-methyl-3-(4-(trifluoromethyl) phenyl) but-2-enamide (1bf): Following the
general procedure for the synthesis of Weinreb amides, purification by flash column
chromatography (silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound
was obtained as a pale yellow liquid, 81% yield The spectroscopic data was consistent with the
literature.99 1HNMR (400 MHz, CDCl3) δ 7.64-7.58 (m, 4H), 6.63 (s, 1H), 3.73 (s, 3H), 3.28 (s,
3H), 2.54 (d, J = 1.2 Hz, 3H) ppm;

13

CNMR (100 MHz, CDCl3) δ 167.1, 150.0, 146.2, 130.0,

126.3, 125.0, 123.8, 117.6, 61.2, 31.8, 17.5. HRMS calculated for C13H14F3NO2, 239.0713, found
239.0717.
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(E)-3-(4-chlorophenyl)-N-methoxy-N-methylbut-2-enamide (1bg): Following the general
procedure for the synthesis of Weinreb amides, purification flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a pale
yellow liquid, 66% yield. The spectroscopic data was consistent with the literature.93 1 HNMR (400
MHz, CDCl3) δ 7.42-7.39 (m, 2H), 7.31-7.29 (m, 2H), 6.57 (s, 1H), 3.70 (s, 3H), 3.25 (s, 3H), 2.49
(s, 3H) ppm; 13CNMR (100 MHz, CDCl3) δ 166.9, 150.0, 140.6, 133.8, 128.0, 127.0, 115.8, 60.9,
31.6, 17.1 ppm; HRMS calculated for C12H14ClNO2: 239.0611, found 239.0718.

(E)-3-(4-cyanophenyl)-N-methoxy-N-methylbut-2-enamide (1bh): Following the general
procedure for the synthesis of Weinreb amides, purification by flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
pale yellow liquid, 70% yield. The spectroscopic data was consistent with the literature. 1H NMR
(100 MHz, CDCl3) δ 7.74 (q, J = 7.6 Hz, 4H), 6.22 (d, J = 1.0 Hz, 1H), 3.84 (s, 3H), 3.37 (s, 3H),
2.05 (d, J = 0.9 Hz, 3H). 13CNMR (100 MHz, CDCl3) δ 206.04, 195.10, 164.61, 159.18, 158.39,
147.30, 143.53, 132.61, 127.14, 122.86, 119.12, 109.07, 81.03, 57.58, 48.04, 34.18, 18.05, 2.14,
19.59.
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(E)-N-methoxy-N-methyl-3-phenylpent-2-enamideate (1bi): Following the general procedure
for the synthesis of Weinreb amides, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a pale
yellow liquid, 53% yield. The spectroscopic data was consistent with the literature.28 1HNMR (400
MHz, CDCl3) δ 7.44-7.41 (m, 2H), 7.36-7.27 (m, 3H), 6.46 (s, 1H), 3.63 (s, 3H), 3.22 (s, 3H), 3.06
(q, J = 7.2 Hz, 2H), 1.07 (t, J = 7.6 Hz, 3H) ppm; 13CNMR (100 MHz, CDCl3) δ 166.8, 158.0,
141.1, 127.9, 127.8, 126.1, 115.1, 60.8, 31.5, 23.7, 13.0 ppm; HRMS calculated for C13H17NO2:
219.1260, found 219.1599.

(E)-N-methoxy-N, 4-dimethyl-3-phenylpent-2-enamide (1bj): Following the general procedure
for the synthesis of Weinreb amides, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a pale
yellow liquid, 70% yield. The spectroscopic data was consistent with the literature.85 1HNMR (400
MHz, CDCl3) δ = 7.36-7.30 (m, 3H), 7.27-7.20 (m, 2H), 6.09 (br s, 1H), 3.90-4.00 (m, 1H), 3.68
(s, 3H), 3.25 (s, 3H), 1.40 (d, J = 7.1 Hz, 6H).
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(E)-3-cyclohexyl-N-methoxy-N-methyl-3-phenylacrylamide (1bk): Following the general
procedure for the synthesis of Weinreb amides, purification by flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
colorless oil, 60% yield. The spectroscopic data was consistent with the literature.28 1HNMR (400
MHz, CDCl3) δ 7.30–7.35 (m, 3H), 7.18–7.21 (m, 2H), 6.07 (s, 1H), 3.67 (s, 3H), 3.25 (s, 3H),
1.61–1.77 (m, 5H), 1.33–1.43 (m, 2H), 1.19–1.29 (m, 3H), 1.02–1.10 (m, 1H); 13CNMR (100 MHz,
CDCl3) δ 142.1, 127.8, 127.6, 127.1, 117.4, 61.4, 40.8, 32.6, 31.7, 26.4, 26.0.

(E)-N-methoxy-N, 3, 4, 4-tetramethylpent-2-enamide (1bl): Following the general procedure
for the synthesis of Weinreb amides, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a colorless
liquid, 78% yield. The spectroscopic data was consistent with the literature.100 1HNMR (400 MHz,
CDCl3) δ 6.16 (s, 1H), 3.66 (s, 3H), 3.19 (s, 3H), 2.08 (s, 3H), 1.12 (s, 9H) ppm; 13CNMR (100
MHz, CDCl3) δ 168.1, 161.1, 111.3, 60.4, 36.8, 31.5, 27.9, 14.1 ppm; HRMS calculated for
C10H19NO2: 185.1566, found: 185.1479.
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(E)-N-methoxy-N,3-dimethyl-5-phenylpent-2-enamide

(1bm):

Following

the

general

procedure for the synthesis of Weinreb amides, purification by flash column chromatography
(silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a
colorless liquid, 90% yield. 1H NMR (400 MHz, CDCl3) δ 7.25 (dd, J = 9.0, 6.0 Hz, 2H), 7.20 –
7.10 (m, 3H), 5.88 (d, J = 0.7 Hz, 1H), 3.86 (s, 3H), 3.30 (s, 3H), 2.63 (t, J = 8.0 Hz, 2H), 2.43 (t,
J = 8.0 Hz, 2H), 2.03 (d, J = 0.6 Hz, 3H). 13CNMR (100 MHz, CDCl3) δ 222.60, 165.57, 158.33,
150.29, 140.99, 128.85, 128.75, 126.52, 117.44, 88.01, 57.58, 41.13, 34.18, 34.14, 18.96, 19.69.

Synthesis of α, β-unsaturated ketones

In a flame dried flask with magnetic stirrer was added Weinreb amide # (1 equiv.)
suspended in THF (12mL). The reaction mixture was then cooled to -30oC and the corresponding
Grignard reagent [CAUTION: Flammable liquid. Water reactive. In case of fire, do not use water
or carbon dioxide. Reacts violently with water. May form explosive peroxides] (1.5 equiv.) was
slowly added dropwise. The mixture was then allowed to warm to -5oC and monitored by TLC
until completion. Saturated aqueous ammonium chloride (20 mL) was added to the reaction
mixture and the organic and aqueous phases separated. The aqueous phase was extracted with
ethyl acetate (3 x 10 mL) and the combined organic phases were then dried over anhydrous sodium
sulfate and the solvent was evaporated in vacuo. The crude product was then purified by flash
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column chromatography (silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The eluent was
collected in Fisherbrand™ disposable borosilicate glass tubes with plain end (Cat. No. 14-961-29
16x100mm) and the corresponding fractions collected were concentrated in vacuo to give the
desired α, β-unsaturated ketone.

(E)-1,3-diphenylbut-2-en-1-one (1a): Following the general procedure for the synthesis of α, βunsaturated ketones, purification by flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow oil, 92% yield. The
spectroscopic data was consistent with the literature.28 (E)-isomer: 1HNMR (400 MHz, CDCl3) δ
7.99 (d, J = 7.0 Hz, 2H), 7.58-7.53 (m, 3H), 7.49-7.39 (m, 5H), 7.17 (q, J = 1.2 Hz, 1H), 2.60 (d,
J = 1.2 Hz, 3H); 13CNMR (100 MHz, CDCl3) δ 191.9, 155.2, 142.8, 139.4, 132.6, 129.2, 128.7,
128.6, 128.4, 126.6, 122.2, 19.0; HRMS calculated for C16H14O, 222.10; found 222.10. (Z)-isomer:
1

HNMR (400 MHz, CDCl3) δ 7.84 (d, J = 4.0 Hz, 2H), 7.44 (t, J = 7.3 Hz, 1H), 7.34 (t, J = 5.0 Hz,

2H), 7.24-7.16 (m, 5H), 6.69 (q, J = 1.3 Hz, 1H), 2.31 (d, J = 1.4 Hz, 3H); 13CNMR (100 MHz,
CDCl3) δ 193.3, 152.6, 140.7, 138.1, 132.6, 128.9, 128.4, 128.2, 128.1, 127.5, 124.3, 26.7; HRMS
calculated for C16H14O : 222.1110; found 222.1008.

(E)-3-(naphthalen-2-yl)-1-phenylbut-2-en-1-one (1b): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
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oil, 79% yield. The spectroscopic data was consistent with the literature.101 1HNMR (CDCl3) δ
8.00-8.05 (3H, m), 7.84-7.92 (3H, m), 7.70 (1H, dd, J = 8.6 Hz), 7.57 (1H, tt, J = 7.4, 1.3 Hz),
7.47-7.54 (4H, m), 7.32 (1H, d, J = 1.2 Hz), 2.71 (3H, d, J = 1.2 Hz); 13CNMR (CDCl3) δ 192.0,
154.8, 139.9, 139.4, 133.5, 133.2, 132.5, 128.6, 128.5, 128.2, 128.3, 127.8, 126.7, 126.6, 126.2,
124.1, 122.5, 18.9.

(E)-3-(naphthalen-1-yl)-1-phenylbut-2-en-1-one (1c): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a white
solid, 25% yield. The spectroscopic data was consistent with the literature.102 1HNMR (400 MHz,
CDCl3) δ 8.01-7.96 (m,3), 7.92-7.88 (m, 1H), 7.85 (d, J = 8.2 Hz, 1H), 7.57-7.44 (m, 6H), 7.38
(dd, J = 7.0 Hz, 1.1Hz, 1H), 7.06 (q, J = 1.3 Hz, 1H), 2.68 (d, J = 1.3 Hz, 3H); 13CNMR (100 MHz,
CDCl3) δ 191.5, 156.9, 142.7, 139.1, 133.8, 132.7, 130.3, 128.7, 128.6, 128.4, 128.3, 126.5, 126.1,
125.5, 125.4, 125.1, 124.4, 22.6; HRMS calculated for C20H16O, 272.1099; found 272.1100.

(E)-3-(4-methoxyphenyl)-1-phenylbut-2-en-1-one (1d): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
oil, 68% yield. The spectroscopic data was consistent with the literature.102 1HNMR (400 MHz,
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CDCl3) δ 8.00-7.97 (m, 2H), 7.55 (t, J = 8.6 Hz, 3H), 7.47 (t, J = 7.3 Hz, 2H), 7.16 (d, J = 1.2 Hz,
1H), 6.95-6.93 (m, 2H), 3.86 (s, 2H), 2.60 (d, J = 1.2 Hz, 3H);

13

CNMR (100 MHz, CDCl3) δ

191.8, 160.6, 154.8, 139.6, 134.8, 132.3, 128.5, 127.9, 120.3, 113.9, 55.4, 18.6; HRMS calculated
for C17H16O2, 252.1150; found 252.1147.

(E)-1-(4-methoxyphenyl)-3-phenylbut-2-en-1-one (1e): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
oil, 71% yield. The spectroscopic data was consistent with the literature.103 1HNMR (400 MHz,
CDCl3) δ 8.00 (2H, d, J = 8.9 Hz), 7.55-7.59 (2H, m), 7.37-7.45 (3H, m), 7.13 (1H, d, J = 1.2 Hz),
6.96 (2H, d, J = 8.9 Hz), 3.88 (3H, s), 2.57 (3H, d, J = 1.2 Hz); 13CNMR (100 MHz, CDCl3) δ
190.7, 163.2, 153.7, 142.9, 132.2, 130.6, 128.9, 128.6, 126.4, 122.3, 113.7, 55.5, 18.8.

(E)-3-(4-fluorophenyl)-1-phenylbut-2-en-1-one (1f): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by column chromatography (silica gel,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a white solid, 91% yield. The
spectroscopic data was consistent with the literature.101 1H NMR (400 MHz, CDCl3) δ 7.88 – 7.76
(m, 2H), 7.65 – 7.49 (m, 3H), 7.49 – 7.43 (m, 2H), 7.19 – 7.12 (m, 3H), 2.12 – 2.08 (m, 3H). 13C
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NMR (100 MHz, CDCl3 δ 190.70, 178.42, 164.64, 162.54, 156.79, 138.81, 138.77, 138.01, 133.11,
128.72, 128.43, 128.41, 128.36, 120.75, 114.72, 114.51, 66.23, 52.01, 18.05, 3.43, 18.24.

(E)-1-(4-fluorophenyl)-3-phenylbut-2-en-1-one (1g): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
oil, 54% yield. The spectroscopic data was consistent with the literature.101 1HNMR (400 MHz,
CDCl3) δ 8.02 (2H, m), 7.55-7.59 (2H, m), 7.38-7.45 (3H, m), 7.15 (2H, t, J =8.6 Hz), 7.12 (1H,
s), 2.59 (3H, s); 13CNMR (100 MHz, CDCl3) δ 220.17, 190.70, 179.92, 166.41, 164.32, 156.79,
141.14, 134.71, 134.68, 131.03, 130.98, 127.95, 127.87, 126.43, 120.75, 115.67, 115.46, 65.47,
58.25, 18.05, 9.67, 2.97, 1.43, 4.25, 12.76.

(E)-1-phenyl-3-(4-(trifluoromethyl)phenyl) but-2-en-1-one (1h): Following the general
procedure for the synthesis of α, β-unsaturated ketones, purification by flash column
chromatography (silica gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound
was obtained as a white solid, 75% yield. The spectroscopic data was consistent with the
literature.104 1H NMR (400 MHz, CDCl3) δ 8.03 – 7.95 (m, 3H), 7.74 – 7.40 (m, 3H), 7.36 (d, J =
7.4 Hz, 3H), 7.16 (s, J = 1.3 Hz, 1H), 2.58 (d, J = 1.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ
190.70, 175.61, 156.79, 142.58, 138.01, 133.11, 131.07, 130.85, 130.64, 130.43, 128.72, 128.43,
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127.60, 126.84, 126.81, 126.78, 126.74, 125.51, 125.45, 125.40, 125.34, 123.41, 121.32, 120.75,
70.61, 48.82, 18.05, 3.72,18.25.

(E)-3-(4-chlorophenyl)-1-phenylbut-2-en-1-one (1i): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by column flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
oil, 70% yield. The spectroscopic data was consistent with the literature.102 1HNMR (400 MHz,
CDCl3) δ 7.98 (d, J = 2.8 Hz, 2H), 7.56 (t, J = 7.3 Hz, 1H), 7.52-7.46 (m, 4H), 7.39 (d, J = 8.7 Hz,
2H), 7.14 (d, J = 1.2 Hz, 1H), 2.56 (d, J = 1.2 Hz, 3H); 13CNMR (100 MHz, CDCl3) δ 191.8, 153.5,
141.1, 139.2, 135.2, 132.8, 128.9, 128.7, 128.4, 127.9, 122.5, 18.8; HRMS calculated for
C16H13ClO: 256.0668; found 256.0612.

4-(4-oxo-4-phenylbutan-2-yl) benzonitrile (1k): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
oil, 70% yield. The spectroscopic data was consistent with the literature.105 1HNMR (400 MHz,
CDCl3) δ 7.99-7.97 (m, 2H), 7.71 (dt, J = 8.1 Hz, 1.7 Hz, 2H), 7.65 (dt, J = 8.1 Hz, 1.7 Hz, 2H),
7.58 (t, J = 7.3 Hz, 2H), 7.19 (q, J = 1.2 Hz, 1H), 4.44-4.39 (m, 2H), 2.59 (d, J = 1.3 Hz, 3H), 1.42
(t, J = 7.1 Hz, 3H); 13CNMR (100 MHz, CDCl3) δ 191.7, 152.1, 147.3, 138.8, 133.1, 132.6, 128.8,
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128.5, 127.2, 124.5, 118.6, 112.6, 18.7; HRMS calculated for C17H13NO : 247.1001, found
247.0899.

(E)-1, 3-diphenylpent-2-en-1-one (1l): Following the general procedure for the synthesis of α, βunsaturated ketones, purification flash column chromatography (silica gel/material =15:1,
hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow oil, 81% yield. The
spectroscopic data was consistent with the literature.28 1HNMR (400 MHz, CDCl3): δ = 8.01-8.05
(m, 2H), 7.40-7.60 (m, 8H), 7.08 (s, 1H), 3.12 (q, J = 7.4 Hz, 2H), 1.18 (t, J = 7.4 Hz, 3H); 13CNMR
(100 MHz, CDCl3): δ = 191.5, 161.4, 141.6, 139.3, 132.6, 129.0, 128.7, 128.6, 128.4, 126.9, 121.9,
25.1, 13.7; HRMS calculated C17H16O, 236.1012, found 236.0998.

(E)-4-methyl-1, 3-diphenylpent-2-en-1-one (1m): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
oil, 88% yield. The spectroscopic data was consistent with the literature.47 1NMR (400 MHz,
CDCl3): δ = 7.99-8.01 (m, 2H), 7.31-7.57 (m, 8H), 6.70 (s, 1H), 3.87-3.94 (m, 1H), 1.15 (d, J =
7.2 Hz, 6H); 13CNMR (100 MHz, CDCl3): δ = 191.9, 165.6, 141.2, 138.9, 132.6, 128.5, 128.4,
127.9, 127.8, 127.6, 123.8, 30.7, 21.7; HRMS calculated for C18H18O: 250.1278. Found 250.1282.
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(E)-3-cyclohexyl-1,3-diphenylprop-2-en-1-one (1n): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
oil, 76% yield. The spectroscopic data was consistent with the literature.85 1HNMR (400 MHz,
CDCl3): δ = 7.98-8.00 (m, 2H), 7.28-7.56 (m, 8H), 6.68 (s, 1H), 3.53-3.61 (m, 1H), 1.64-1.82 (m,
5H), 1.27-1.45 (m, 4H), 1.03-1.14 (m, 1H),; 13CNMR (100 MHz, CDCl3): δ = 191.8, 165.6, 141.9,
139.0, 132.6, 128.5, 128.4, 127.8, 127.7, 127.5, 123.8, 41.6, 31.8, 26.5, 26.1; HRMS calculated
for C21H22O, 290.1604, found 290.1655.

(E)-3, 4, 4-trimethyl-1-phenylpent-2-en-1-one (1o): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
oil, 70% yield. The spectroscopic data was consistent with the literature.106 1H NMR (400 MHz,
CDCl3) δ 1.13 (s, 9H), 1.20 (s, 9H), 2.16 (d, J = 1.0 Hz, 3H), 3.70 (s, 2H), 4.67 (s, 1H), 5.08 (s,
1H), 6.76 (d, J = 1.0 Hz, 1H), 7.40−7.56 (m), 7.83−8.03 (m).
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(E)-3-methyl-1, 5-diphenylpent-2-en-1-one (1p): Following the general procedure for the
synthesis of α, β-unsaturated ketones, purification by flash column chromatography (silica
gel/material =15:1, hexanes/EtOAc = 30:1→10:1). The title compound was obtained as a yellow
solid, 86% yield. The spectroscopic data was consistent with the literature.28 1HNMR (400 MHz,
CDCl3): δ = 7.76-7.79 (m, 2H), 7.21-7.53 (m, 8H), 6.62 (s, 1H), 2.89 (t, J = 7.8 Hz, 1H), 2.57 (t, J
= 7.7 Hz, 1H), 2.23 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 191.7, 157.9, 141.0, 139.1, 132.3,
128.5, 128.4, 128.3, 128.2, 126.1, 121.6, 43.1, 34.1, 19.9; HRMS calculated for C18H18O: 250.1399,
found 250.1396.
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Appendix III
Chemical vendor information
reagent
sodium hydride (60% dispersion in oil)
anhydrous THF
triethyl phosphonoacetate
sodium bicarbonate
ethyl acetate
sodium sulfate
hexanes
diethyl ether
acetophenone
1-Acetylnaphthalene
2-Acetylnaphthalene
4'-Methoxyacetophenone
1-(4-Fluorophenyl)ethanone
1-(4-chlorophenyl)ethan-1-one
propiophenone
2-methyl-1-phenylpropan-1-one
cyclohexyl(phenyl)methanone
2,2,2-trifluoro-1-phenylethan-1-one
1-(4-(trifluoromethyl)phenyl)ethan-1-one
3,3-dimethylbutan-2-one
4,4,5,5-Tetramethyl-1,3,2-dioxaborolane
4-phenylbutan-2-one
N,O-Dimethylhydroxylamine hydrochloride
isopropylmagnesium chloride solution 2.0 M in THF
dichloromethane
benzaldehyde
anhydrous cyclohexane
potassium carbonate
deuterated chloroform (CDCl3)

cas #
7646-69-7
109-99-9
867-13-0
144-55-8
141-78-6
7757-82-6
110-54-3
60-29-7
98-86-2
941-98-0
93-08-3
100-06-1
403-42-9
99-91-2
93-55-0
611-70-1
712-50-5
434-45-7
709-63-7
75-97-8
25015-63-8
2550-26-7
6638-79-5
1068-55-9
75-09-2
100-52-7
110-82-7
584-08-7
865-49-6

vendor
Sigma-Aldrich
Fisher Scientific
Fisher Scientific
Sigma-Aldrich
Fisher Scientific
Fisher Scientific
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
AK Scientific
AK Scientific
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Fisher Scientific
Fisher Scientific
Fisher Scientific
Fisher Scientific
Sigma-Aldrich
Alfa-Aesar
Sigma-Aldrich
Fisher Scientific
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Fisher Scientific
Fisher Scientific
Sigma-Aldrich

(R)-(+)-1,1′-Bi(2-naphthol)
(S)-(−)-1,1′-Bi(2-naphthol)
tribromoboron (BBr3)
methanol (MeOH)

18531-94-7
18531-99-2
10294-33-4
67-56-1

Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
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tetrakis(triphenylphosphine)palladium(0)
pyridine
phosphorous oxychloride (POCl3)
1,2-Dimethoxyethane

14221-01-3
110-86-1
10025-87-3
110-71-4
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Fisher Scientific
Fisher Scientific
Sigma-Aldrich
Fisher Scientific

Appendix IV
1

HNMR spectra of 1,4-reduction starting material and product

(E)-1, 3-diphenylbut-2-en-1-one

94

1,3-diphenylbutan-1-one

95

(E)- 3-(naphthalen-2-yl)-1-phenylbut-2-en-1-one

96

3-(naphthalen-2-yl)-1-phenylbutan-1-one

97

(E)-3-(naphthalen-1-yl)-1-phenylbut-2-en-1-one

98

3-(naphthalen-1-yl)-1-phenylbutan-1-one

99

(E)-3-(4-methoxyphenyl)-1-phenylbut-2-en-1-one

100

3-(4-methoxyphenyl)-1-phenylbutan-1-one

101

(E)-1-(4-methoxyphenyl)-3-phenylbut-2-en-1-one

102

1-(4-methoxyphenyl)-3-phenylbutan-1-one

103

(E)-3-(4-fluorophenyl)-1-phenylbut-2-en-1-one

104

3-(4-fluorophenyl)-1-phenylbutan-1-one

105

(E)-1-(4-fluorophenyl)-3-phenylbut-2-en-1-one

106

1-(4-fluorophenyl)-3-phenylbutan-1-one

107

(E)-1-phenyl-3-(4-(trifluoromethyl)phenyl)but-2-en-1-one

108

1-phenyl-3-(4-(trifluoromethyl)phenyl)butan-1-one

109

(E)-3-(4-chlorophenyl)-1-phenylbut-2-en-1-one

110

3-(4-chlorophenyl)-1-phenylbutan-1-one

111

(E)-4-(4-oxo-4-phenylbut-2-en-2-yl)benzonitrile

112

4-(4-oxo-4-phenylbutan-2-yl)benzonitrile

113

(E)-1,3-diphenylpent-2-en-1-one

114

1,3-diphenylpentan-1-one

115

(E)-4-methyl-1,3-diphenylpent-2-en-1-one

4-methyl-1,3-diphenylpentan-1-one
116

117

(E)-3-cyclohexyl-1,3-diphenylprop-2-en-1-one

118

3-cyclohexyl-1,3-diphenylpropan-1-one

119

(E)-3,4,4-trimethyl-1-phenylpent-2-en-1-one

120

3,4,4-trimethyl-1-phenylpentan-1-one

121

(E)-3-methyl-1,5-diphenylpent-2-en-1-one

122

3-methyl-1, 5-diphenylpentan-1-one

123

Appendix V
HPLC Spectra for 1,4-reduction of α, β-unsaturated ketones
1,3-diphenylbutan-1-one

124

3-(naphthalen-2-yl)-1-phenylbutan-1-one

125

3-(naphthalen-1-yl)-1-phenylbutan-1-one

126

3-(4-methoxyphenyl)-1-phenylbutan-1-one

127

1-(4-methoxyphenyl)-3-phenylbutan-1-one

128

3-(4-fluorophenyl)-1-phenylbutan-1-one

129

1-(4-fluorophenyl)-3-phenylbutan-1-one

130

3-(4-chlorophenyl)-1-phenylbutan-1-one

131

1-phenyl-3-(thiophen-2-yl)butan-1-on

132

4-(4-oxo-4-phenylbutan-2-yl)benzonitrile

133

1,3-diphenylpentan-1-one

134

4-methyl-1,3-diphenylpentan-1-one

135

3-cyclohexyl-1,3-diphenylpropan-1-one

136

3-methyl-1,5-diphenylpentan-1-one

137

Appendix VI
HPLC chromatograms of reductive aldol reaction
Compound (3.2a):
(2R,3R)-2-((R)-hydroxy(phenyl)methyl)-1,3-diphenylbutan-1-one
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Compound (3.2b):
(2R,3R)-2-((R)-hydroxy(phenyl)methyl)-3-(naphthalen-2-yl)-1-phenylbutan-1-one
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Compound (3.2d):
(2R,3R)-2-((R)-hydroxy(phenyl)methyl)-3-(4-methoxyphenyl)-1-phenylbutan-1-one
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Compound (3.2e):
(2R,3R)-1-(4-fluorophenyl)-2-((R)-hydroxy(phenyl)methyl)-3-phenylbutan-1-one
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Compound (3.2f):
(2R,3R)-3-(4-chlorophenyl)-2-((R)-hydroxy(phenyl)methyl)-1-phenylbutan-1-one

142
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